Thrombus aspiration system and methods for controlling blood loss

- Contego Medical, Inc.

Aspiration systems and methods for controlling blood loss during thrombus removal are disclosed herein. The systems include an aspiration catheter, an aspiration tubing, a receptacle for collecting aspirated blood, a vacuum line coupled to the receptacle, and a sensor configured to measure a flow parameter associated with a liquid within an aspiration lumen. The systems further include a regulator configured to adjust a vacuum pressure within the vacuum line, and a vacuum controller operably coupled to the sensor and the regulator. The vacuum controller is configured to receive the flow parameter from the sensor, compare the flow parameter to a target range for the flow parameter, and send an automatic control signal to the regulator based on a comparison of the flow parameter to the target range. The automatic control signal causes the regulator to adjust the vacuum pressure within the vacuum line.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 17/726,791, filed Apr. 22, 2022, which claims the benefit of U.S. Provisional Application 63/180,291, filed Apr. 27, 2021. Each of the aforementioned applications is incorporated herein by reference in its entirety for all purposes.

FIELD

This invention relates to medical devices for thrombus removal, and more particularly to thrombus aspiration systems.

BACKGROUND

It is often desirable to remove tissue from the body in a minimally invasive manner as possible, so as not to damage other tissues. For example, removal of tissue (e.g., blood clots) from the vasculature may improve patient conditions and quality of life.

Many vascular system problems stem from insufficient blood flow through blood vessels. One causes of insufficient or irregular blood flow is a blockage within a blood vessel referred to as a blood clot, or thrombus. Thrombi can occur for many reasons, including after a trauma such as surgery, or due to other causes. For example, a large percentage of the more than 1.2 million heart attacks in the United States are caused by blood clots (thrombi) which form within a coronary artery.

When a thrombus forms, it may effectively stop the flow of blood through the zone of formation. If the thrombus extends across the interior diameter of an artery, it may cut off the flow of blood through the artery. If one of the coronary arteries is 100% thrombosed, the flow of blood is stopped in that artery, resulting in a shortage of oxygen carrying red blood cells, e.g., to supply the muscle (myocardium) of the heart wall. Such a thrombosis is unnecessary to prevent loss of blood but can be undesirably triggered within an artery by damage to the arterial wall from atherosclerotic disease. Thus, the underlying disease of atherosclerosis may not cause acute oxygen deficiency (ischemia) but can trigger acute ischemia via induced thrombosis. Similarly, thrombosis of one of the carotid arteries can lead to stroke because of insufficient oxygen supply to vital nerve centers in the cranium. Oxygen deficiency reduces or prohibits muscular activity, can cause chest pain (angina pectoris), and can lead to death of myocardium which permanently disables the heart to some extent. If the myocardial cell death is extensive, the heart will be unable to pump sufficient blood to supply the body's life sustaining needs. The extent of ischemia is affected by many factors, including the existence of collateral blood vessels and flow which can provide the necessary oxygen.

Clinical data indicates that clot removal may be beneficial or even necessary to improve outcomes. For example, in the peripheral vasculature, inventions and procedures can reduce the need for an amputation by 80 percent. The ultimate goal of any modality to treat these conditions of the arterial or venous system is to remove the blockage or restore patency, quickly, safely, and cost effectively. This may be achieved by thrombus dissolution, fragmentation, thrombus aspiration or a combination of these methods.

Catheter directed thrombectomy and thrombolysis are commonly perceived to be less traumatic, less likely to decrease the morbidity and mortality associated with conventional surgical techniques. In recent years, direct administration of chemical lysing agents into the coronary arteries has shown to be of some benefit to patients who have thrombosed coronary arteries. In this procedure, a catheter is placed immediately in front of the blockage and a drip of streptokinase is positioned to be directed at the upstream side of the thrombus. Streptokinase is an enzyme which is able in time to dissolve the fibrin molecule. This procedure can take several hours and is not always successful in breaking up the thrombus. Furthermore, it can lead to downstream thrombus fragments (emboli) which can lead to blockage of small diameter branches.

Thrombectomy is a technique for mechanical removal of blood clots in an artery or vein. It refers to physically removing a clot as opposed to employing chemical lysis to dissolve it. Multiple devices have been introduced to break up and remove clot and plaque, but each has its own shortcomings. Specifically, the existing systems do not provide adequate methods for breaking up the clot into smaller pieces for subsequent aspiration. Also, they do not provide a method for removing the thrombectomy device over a guidewire and reinserting into the same location to complete the procedure. Furthermore, conventional aspiration systems offer little control over the amount of blood lost during the procedure. There is a need for improved thrombectomy devices and aspiration systems that are safer and more effective for removing thrombus and plaque from the vascular system.

SUMMARY

Aspiration systems and methods are disclosed herein for controlling blood loss during thrombus removal. The aspiration systems include, at least, an aspiration catheter, a thrombus retrieval device extending through the aspiration catheter, and an aspiration tubing fluidically coupled to the aspiration catheter. An aspiration lumen extends through the aspiration catheter and the aspiration tubing. A sensor measures a flow parameter associated with a liquid within the aspiration lumen. The aspiration systems further include a receptacle configured to collect liquid aspirated by the aspiration catheter. A vacuum line is fluidically coupled to the receptacle, and a regulator adjusts the vacuum pressure within the vacuum line. A vacuum controller is operably coupled to the sensor and the regulator. The vacuum controller is configured to receive the flow parameter from the sensor, compare the flow parameter to a target range for the flow parameter, and send an automatic control signal to the regulator based on a comparison of the flow parameter to the target range. The automatic control signal causes the regulator to adjust the vacuum pressure within the vacuum line.

In some implementations, the automatic control signal causes the regulator to decrease the vacuum pressure upon a determination that the flow parameter is above an upper limit of the target range, and to increase the vacuum pressure upon a determination that the flow parameter is below a lower limit of the target range. For example, the upper limit can be a flow rate from 70 mL per minute to 130 mL per minute, and the lower limit can be a flow rate from 0 mL per minute to 40 mL per minute. In some examples, the vacuum controller is configured to adjust the flow rate to an intermediate level, such as, for example, from 20 mL per minute to 50 mL per minute. Increases and decreases in vacuum pressure can occur in a stepwise manner. In some implementations, the vacuum controller can activate an aspiration program that causes increases and decreases of vacuum pressure in a stepwise manner. In some examples, the aspiration program is activated upon receipt of information from one or more manual inputs in communication with the regulator, the vacuum controller, or both.

The receptacle is fluidically coupled to the aspiration tubing, the aspiration catheter, and the vacuum line. In some implementations, an intake port on the receptacle provides the coupling between the receptacle and the aspiration tubing, and a vacuum port on the receptacle provides the coupling between the receptacle and the vacuum line. The receptacle can include a receptacle vent in communication with the regulator or the vacuum controller. The receptacle vent opens upon receipt of a venting signal from the regulator or vacuum controller.

The aspiration system includes one or more sensors for measuring flow parameters, such as, for example, a flow rate. Some implementations can include a plurality of sensors configured to measure one or more parameters associated with fluid flow at disparate points along a length of the aspiration lumen, and to send the measured parameters to the vacuum controller. The sensor may or may not contact the liquid within the aspiration lumen.

Some implementations can further include an air leak sensor in communication with the vacuum controller or the regulator. The air leak sensor can detect air flow through the aspiration tubing and send a leak signal to the vacuum controller, the regulator, or the vacuum pump upon detection of air through the aspiration tubing. The vacuum controller, regulator, or pump can slow or stop the vacuum flow while the air leak is addressed. In some implementations, the vacuum controller is configured to delay detection of air leaks during a vacuum initialization period. Alternatively, or in addition, the vacuum controller can be configured to delay controlling the vacuum in response to detection of air leaks during a vacuum initialization period.

In some implementations of the system, the regulator adjusts the vacuum pressure within the vacuum line by manipulating a valve that opens the vacuum line to the atmosphere. In some implementations, the regulator adjusts the vacuum pressure within the vacuum line by manipulating a valve that alters the flow capacity of the vacuum line. The vacuum line can have a disposable portion and a reusable portion. The disposable portion can be coupled to the reusable portion at a connector. Some implementations of the system include a vacuum pump. Some implementations can include a power sensor configured to synchronize the delivery of power between the pump and the vacuum controller.

The vacuum controller sends signals to one or more components of the system to regulate flow of air in the vacuum line and blood through the aspiration lumen. The vacuum controller can be, in some examples, a microprocessor controller. It can include an analog to digital converter and a digital to analog converter. In some examples, the vacuum controller is configured to measure a frequency from the flow parameter. The vacuum controller can operate independently. For example, the vacuum controller is capable of operating without input from external sources such as a computer.

Some implementations of the systems include one or more manual inputs in communication with the vacuum controller, the regulator, and/or a receptacle vent. The manual input is configured to accept a manual command and send a first manual control signal responsive to the manual command to one or more of the vacuum controller, the regulator, and/or the receptacle vent. In some examples, upon receipt of the first manual control signal, the vacuum controller stops one or more steps of comparing the flow parameter to a target range for the flow parameter, forming an automatic control signal, and/or sending the automatic control signal to the regulator. In some implementations, the vacuum controller is configured to send a second manual control signal to the regulator and/or receptacle vent based on the first manual control signal. The regulator controls the vacuum pressure within the vacuum line upon receipt of the first manual control signal and/or the second manual control signal. The receptacle vent opens or shuts upon receipt of the first manual control signal and/or the second manual control signal. Some systems can also include an indicator in communication with the flow sensor. The indicator is configured to inform a user of a characteristic of the flow parameter.

In some implementations, at least one braided assembly extends over a distal region of the thrombus retrieval device. The braided assembly can include a braid having a shape memory of a collapsed configuration.

In some implementations, the aspiration system further comprises a clamp coupled to the aspiration tubing and a switch operably coupled to the clamp, the switch comprising a closed configuration and an open configuration, wherein the switch in the closed configuration causes the clamp to stop fluid flow through the aspiration tubing, and wherein the switch in the open configuration causes the clamp to allow fluid flow through the aspiration tubing. The switch can be in communication with the vacuum controller and/or the regulator. Shifting the switch to the open configuration can send a surge protection signal to the regulator and/or to the vacuum controller. The regulator and/or the vacuum controller can reduce the vacuum pressure upon receipt of the surge protection signal.

Methods of controlling blood loss during thrombus removal are disclosed herein. The methods include positioning an aspiration catheter within the vascular system of a subject and positioning a thrombus retrieval device within the vascular system of the subject through the aspiration catheter. The aspiration catheter is fluidically connected to an aspiration tubing and a vacuum pump. Activation of the vacuum pump initiates the flow of blood through the aspiration catheter and the aspiration tubing. A sensor measures a flow parameter of the blood within the aspiration tubing. The flow parameter from the sensor is received at a vacuum controller. The flow parameter is compared to a target range for the flow parameter, and an automatic control signal is sent to the regulator based on a comparison of the flow parameter to the target range. The vacuum pressure within the vacuum line is adjusted according to information stored in the automatic control signal.

In some implementations, the vacuum pump is activated at full power, and adjustments to the vacuum pressure are regulated by the vacuum controller while the vacuum pump runs at full power.

The step of adjusting the vacuum pressure can include decreasing the vacuum pressure upon a determination that the flow parameter is above an upper limit of the target range (for example, an upper limit of a flow rate from 70 mL per minute to 130 mL per minute). The step of decreasing the vacuum pressure can include lowering the vacuum pressure in a stepwise manner. In some implementations, the vacuum pressure is decreased until the measured flow parameter reaches an intermediate level flow rate of 20 mL per minute to 50 mL per minute. Some methods include a step of activating an aspiration program upon receipt of a manual command from one or more manual inputs in communication with the regulator and/or the vacuum controller, and the aspiration program includes lowering the vacuum pressure in a stepwise manner.

The step of adjusting the vacuum pressure can include increasing the vacuum pressure upon a determination that the flow parameter is below a lower limit of the target range (for example, a lower limit of a flow rate of from 0 mL per minute to 50 mL per minute). the step of increasing the vacuum pressure can include raising the vacuum pressure in a stepwise manner. In some implementations, the vacuum pressure is raised until the measured flow parameter reaches an intermediate level flow rate of 20 mL per minute to 50 mL per minute. Some methods include a step of activating an aspiration program upon receipt of a manual command from one or more manual inputs in communication with the regulator and/or the vacuum controller, and the aspiration program includes raising the vacuum pressure in a stepwise manner.

In some implementations, the step of adjusting the vacuum pressure within the vacuum line comprises manipulating a valve that opens the vacuum line to the atmosphere. In some implementations, the step of adjusting the vacuum pressure within the vacuum line alters the flow capacity of the vacuum line.

The step of measuring a flow parameter can include measuring a flow rate. Some method implementations use a plurality of sensors to measure one or more flow parameters of the blood at disparate points along the length of the aspiration lumen. The one or more flow parameters are received at the vacuum controller. The methods can further include a step of measuring a frequency from the flow parameter at the vacuum controller.

Some method implementations can include a step of detecting air within the aspiration tubing and sending a leak signal to the regulator, the pump, or to the vacuum controller. In some implementations, the step of detecting air within the aspiration tubing or the step of sending a leak signal to the regulator or the pump is delayed during initialization of the vacuum.

Some method implementations can include a step of accepting a manual command at a manual input and sending a first manual control signal responsive to the manual command to one or more of the vacuum controller, the regulator, or a receptacle vent. Upon receipt of the first manual control signal, the vacuum controller can stops sending automatic control signals to the regulator. In some implementations, a second manual control signal is formed at the vacuum controller (based on the first manual control signal) and the second manual control signal is sent to the regulator and/or receptacle vent. Some method implementations can include a step of receiving the first manual control signal or the second manual control signal at the regulator and controlling vacuum pressure within the vacuum line based on the first manual control signal or the second manual control signal. Some method implementations can include a step of receiving the first manual control signal or the second manual control signal at the receptacle vent and opening or shutting the vent based on the first manual control signal or the second manual control signal.

Some method implementations can include a step of receiving information from the flow sensor at an indicator and informing a user of a characteristic of the flow parameter using the indicator.

Some method implementations can include a step of shifting a switch from a closed configuration to an open configuration, wherein shifting the switch to the open configuration causes a clamp coupled to the aspiration tubing to allow fluid flow through the aspiration tubing. A surge protection signal can be sent upon shifting of the switch to the open configuration and received at the controller or regulator. The vacuum pressure can be decreased upon receipt of the surge protection signal.

Some method implementations can include a step of synchronizing the delivery of power between the vacuum pump and the vacuum controller.

DESCRIPTION OF DRAWINGS

The device is explained in even greater detail in the following drawings. The drawings are merely exemplary and certain features may be used singularly or in combination with other features. The drawings are not necessarily drawn to scale.

FIG. 1A is a side section view of an implementation of the thrombectomy device having a single braided assembly in the collapsed configuration.

FIG. 1B is a side view showing the distal region of the thrombectomy device carrying the braided assembly of FIG. 1A. The braided assembly is shown in an expanded configuration.

FIG. 1C is a side view showing the distal region of the thrombectomy device of FIG. 1A. The braided assembly is not included in this view.

FIG. 1D is a cross sectional view of the implementation of FIG. 1A, taken along lines A-A of FIG. 1C.

FIG. 2 shows a side view of an implementation of a handle that can be used to control expansion and retraction of a braided assembly.

FIG. 3A is a side view of a distal region of an additional implementation of the thrombectomy device in an unexpanded configuration. The implementation has a braided assembly having multiple braided sections.

FIG. 3B is a side view of the distal region of the implementation of FIG. 3A in an expanded configuration.

FIG. 3C is a side view of the distal region of the thrombectomy device of FIG. 3A. The braided assembly is not included in this view.

FIG. 3D shows a cross sectional view taken along line 3D-3D of FIG. 3C.

FIG. 3E shows a cross sectional view taken along line 3E-3E of FIG. 3C.

FIG. 3F shows a cross sectional view taken along line 3F-3F of FIG. 3C.

FIG. 3G shows a cross sectional view taken along line 3G-3G of FIG. 3C.

FIG. 4 shows an additional implementation of the thrombectomy device having multiple expandable braided assemblies.

FIG. 5A shows a side section view of an implementation of the thrombectomy device that enables use with a guidewire.

FIG. 5B shows the implementation of FIG. 5A in an expanded configuration.

FIG. 5C is a cross section of the implementation of FIGS. 5A and 5B, taken along line B-B of FIG. 5B.

FIGS. 6A-6F show an example method of using a thrombectomy device.

FIG. 7A shows a perspective view of another implementation of a handle that can be used to control expansion and retraction of a braided assembly.

FIG. 7B shows a bottom up, inside view of the locking slider of the handle implementation of FIG. 7A.c

FIG. 7C shows a cross section of the locking slider circled in FIG. 7B.

FIG. 8 is a diagram of an aspiration system for controlling blood loss during thrombus removal.

FIG. 9 is a flow chart of a method for controlling blood loss during thrombus removal.

FIG. 10 is a line graph depicting a flow rate through an aspiration tubing over time.

FIG. 11 is another line graph depicting a flow rate through an aspiration tubing over time.

FIG. 12 is a diagram of a computing device upon which the disclosed systems may be implemented.

FIG. 13 shows a proximal end of an aspiration catheter connected via an adapter to an aspiration tubing.

 DETAILED DESCRIPTION

The systems and methods disclosed herein aim to reduce the amount of blood lost during procedures that utilize aspiration to remove thrombus from the vasculature. The systems include a vacuum controller for an aspiration pump that is used in conjunction with an aspiration catheter and an aspiration tubing. The aspiration tubing is equipped with a flow sensor in communication with vacuum controller. The vacuum controller monitors the flow rate of blood being aspirated by the pump and communicates with a vacuum regulator to raise the vacuum if the flow rate gets to low (for example, when obstructed by a clot). The vacuum controller also communicates with the vacuum regulator to lower the vacuum if the flow rate gets too high. This lowering of the vacuum is a safety feature designed to prevent the system from aspirating blood instead of clot. Applying only the vacuum needed to remove the clot prevents unnecessary blood loss. Furthermore, damage to the vasculature is reduced because the amount of time the system applies full vacuum is minimized. The system can increase or decrease pressure gradually, or in a stepwise manner, to ensure the practitioner has sufficient time to respond to sudden changes in flow rate. The system can also include a variety of manual inputs to slow, pause, or stop the automated flow control processes.

The system disclosed herein integrates flow and vacuum control, using flow rate to inform the desired vacuum level. Conventional systems do not offer this feature. Many prioritize improving aspiration efficiency over controlling blood loss. Furthermore, conventional systems often adjust vacuum level based on pressure sensors within the aspiration tubing. Because the disclosed system responds specifically to the parameter of interest—the amount of blood flowing through the catheter—it responds more accurately than pressure measurement-based systems. With this system, the user can tune the flow rate, defining minimum and maximum allowed flow rates, and then automate control of the vacuum and flow rate according to those thresholds. This automation reduces the need for the practitioner to monitor and adjust the procedure for blood loss (though the practitioner is able to override the automation when necessary, via the aforementioned manual inputs). Advantageously, the system minimizes the necessary procedure time by optimizing the aspiration process.

The aspiration system can be used with a variety of catheters and vacuum pumps without changing the core aspiration system. It can be provided with all of the necessary components, or can be used with components that are provided by the clinician. Furthermore, the vacuum controller, regulator, and pump can be used in the operating theater but fluidically isolated from the patient, negating the need for extensive sterilization. Flow manipulation occurs within the vacuum line instead of the aspiration lumen—a cleaner design than some conventional systems where valves directly manipulate blood flow within the aspiration lumen. In the disclosed aspiration systems, components that do contact blood can be disposable, whereas fluidically isolated components can be reusable.

The thrombectomy devices disclosed herein remove a thrombus using a braided assembly that can be expanded to a diameter of the practitioner's choosing, enabling the practitioner to custom fit the device to the particular vessel and thrombus and during the procedure. Unlike conventional thrombectomy devices, the diameter of the disclosed braided assembly can be changed mid-procedure as needed. For example, the braided assembly can be opened to a wider diameter to apply more outward force against the thrombus should additional grip be needed for its removal. In some implementations, multiple braided assemblies can be used to address longer thrombi. Each braided assembly can be separately expanded, such that the individual assemblies have different diameters during the procedure.

The device disclosed herein is used to the remove a thrombus, clot, or plaque from the veins or arteries of the body. It includes an aspiration catheter and a retrieval device that extends through the lumen of the aspiration catheter. An expandable braided assembly extends over a distal region of the retrieval device, such that when the retrieval device exits the distal end of the aspiration catheter, the braided assembly is positioned outside of the aspiration catheter. An activation wire extends through the lumen of the retrieval device. The distal end of the activation wire exits the retrieval device at an exit point to connect to and control the expansion of a braided assembly. On the proximal end, the activation wire is attached to a tensioning element. Applying tension to the activation wire causes the braided assembly to expand to a diameter of the practitioner's choosing. For example, the practitioner may apply a first level of tension to deploy the braided assembly to a first, partially expanded configuration and then later decide to widen the diameter to the fully expanded configuration by applying a greater level of tension to the activation wire. The expanded braided assembly contacts the thrombus, clot, or plaque and is pulled proximally toward the aspiration catheter to assist in removal. Hereinafter the device and methods will be described as removing (or being configured to remove) a thrombus. However, it will be understood that the device can also be used to remove clots or plaques from the vasculature with no structural (or only slight structural) modifications. Various implementations of the thrombectomy catheter include a retrieval device with multiple braided assemblies, multiple activation wires, multiple braided sections of a single braided assembly, and retrieval devices with multiple lumens to, for example, enable use with a guidewire.

The following description of certain examples of the inventive concepts should not be used to limit the scope of the claims. Other examples, features, aspects, configurations, implementations, and advantages will become apparent to those skilled in the art from the following description. As will be realized, the device and/or methods are capable of other different and obvious aspects, all without departing from the spirit of the inventive concepts. Accordingly, the drawings and descriptions should be regarded as illustrative in nature and not restrictive.

For purposes of this description, certain advantages and novel features of the aspects and configurations of this disclosure are described herein. The described methods, systems, and apparatus should not be construed as limiting in any way. Instead, the present disclosure is directed toward all novel and nonobvious features and aspects of the various disclosed aspects, alone and in various combinations and sub-combinations with one another. The disclosed methods, systems, and apparatus are not limited to any specific aspect, feature, or combination thereof, nor do the disclosed methods, systems, and apparatus require that any one or more specific advantages be present or problems be solved.

Although the operations of exemplary aspects of the disclosed method may be described in a particular, sequential order for convenient presentation, it should be understood that disclosed aspects can encompass an order of operations other than the particular, sequential order disclosed. For example, operations described sequentially may in some cases be rearranged or performed concurrently. Further, descriptions and disclosures provided in association with one particular aspect or implementation are not limited to that aspect or implementation and may be applied to any aspect or implementation disclosed. It will understood that various changes and additional variations may be made and equivalents may be substituted for elements thereof without departing from the scope of the invention or the inventive concept thereof. Certain aspects and features of any given aspect may be translated to other aspects described herein. In addition, many modifications may be made to adapt a particular situation or device to the teachings of the invention without departing from the essential scope thereof. Therefore, it is intended that the invention not be limited to the particular implementations disclosed herein, but that the invention will include all implementations falling within the scope of the appended claims.

Features, integers, characteristics, compounds, chemical moieties, or groups described in conjunction with a particular aspect, configuration, implementation or example of the invention are to be understood to be applicable to any other aspect, configuration, implementation, or example described herein unless incompatible therewith. All of the features disclosed in this specification (including any accompanying claims, abstract, and drawings), and/or all of the steps of any method or process so disclosed, may be combined in any combination, except combinations where at least some of such features and/or steps are mutually exclusive. The invention is not restricted to the details of any foregoing aspects. The invention extends to any novel one, or any novel combination, of the features disclosed in this specification (including any accompanying claims, abstract, and drawings), or to any novel one, or any novel combination, of the steps of any method or process so disclosed.

As used in the specification and the appended claims, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Ranges may be expressed herein as from “about” one particular value, and/or to “about” another particular value. When such a range is expressed, another aspect includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another aspect. It will be further understood that the endpoints of each of the ranges are significant both in relation to the other endpoint, and independently of the other endpoint. The terms “about” and “approximately” are defined as being “close to” as understood by one of ordinary skill in the art. In one non-limiting aspect the terms are defined to be within 10%. In another non-limiting aspect, the terms are defined to be within 5%. In still another non-limiting aspect, the terms are defined to be within 1%.

“Optional” or “optionally” means that the subsequently described event or circumstance may or may not occur, and that the description includes instances where said event or circumstance occurs and instances where it does not.

The terms “coupled,” “connected,” and the like as used herein mean the joining of two members directly or indirectly to one another. Such joining may be stationary (e.g., permanent) or moveable (e.g., removable or releasable). Such joining may be achieved with the two members or the two members and any additional intermediate members being integrally formed as a single unitary body with one another or with the two members or the two members and any additional intermediate members being attached to one another.

The terms “proximal” and “distal” as used herein refer to regions of the aspiration tubing or thrombectomy device. “Proximal” means a region closest to the practitioner during a procedure, while “distal” means a region farther from the practitioner during a procedure.

Throughout the description and claims of this specification, the word “comprise” and variations of the word, such as “comprising” and “comprises,” means “including but not limited to,” and is not intended to exclude, for example, other additives, components, integers or steps. “Exemplary” means “an example of” and is not intended to convey an indication of a preferred or ideal aspect. “Such as” is not used in a restrictive sense, but for explanatory purposes.

A vacuum is a pressure that is less than the local atmospheric pressure. As used herein, “vacuum pressure” indicates the relative pressure, i.e., the differential between ambient pressure and the absolute pressure applied by the vacuum. Thus, an increase in relative vacuum pressure is an increase in the difference between ambient pressure and the absolute vacuum pressure, which increases the force applied by the vacuum. Likewise, a decrease in relative vacuum pressure is a decrease in the difference between ambient pressure and the absolute vacuum pressure, which decreases the force applied by the vacuum.

FIGS. 1A-1D show an implementation of the thrombectomy device 1. FIG. 1A shows the aspiration catheter 106, the retrieval device 3, a collapsed braided assembly 102, and a guidewire tip 103. The aspiration catheter 106 is an elongated tube with reinforced construction that allows a vacuum to be applied at the proximal end to pull clot and emboli out of the artery or vein without collapsing. The aspiration catheter 106 can be formed of a polymer material. The aspiration catheter 106 can include an imaging marker 8 (such as a fluorescent or radiopaque marker) for use in imaging the position of the catheter during a procedure. Thrombus retrieval device 3 extends through aspiration catheter 106. The braided assembly 102 extends over a distal region 5 of the retrieval device 3, such that when the retrieval device 3 exits the distal end 7 of the aspiration catheter 106, the braided assembly 102 is positioned outside of the aspiration catheter 106. In the collapsed configuration, braided assembly 102 is sized and configured for insertion through the aspiration catheter 106 and into an artery or vein. Guidewire tip 103 extends distally from the distal end 107 of the retrieval device 3. The guidewire tip 103 can be flexible, shapeable, and steerable.

The braided assembly 102 is moveable from a collapsed to an expanded configuration. An example of a braided assembly 102 in an expanded configuration is shown in FIG. 1B, but the maximum diameter, dmax, of the expanded braided assembly 102 can be changed to any value over a continuous range, from a fully collapsed diameter, to a partially expanded diameter, to a fully expanded diameter. The maximum diameter of the braided assembly, dmax, is the widest point measured perpendicular to a longitudinal axis, a, extending through the center of the braided assembly 102. The braided assembly 102 can be sized and configured to disrupt and capture one or more clots, plaques, and/or thrombi and pull them toward the aspiration catheter 106 where they can be removed. The braided assembly 102 includes a braid 9, a slidable collar 108, and a fixed attachment point 101 where the braid 9 anchors to the retrieval device 3. The braid 9 may be attached directly to the retrieval device 3 at attachment point 101, or the braid 9 may be attached indirectly to the retrieval device 3 at attachment point 101. In some implementations, the fixed attachment point 101 is a fixed collar that extends around the retrieval device 3, and the braid is welded, bonded, or otherwise adhered to the fixed collar. Regardless, at the fixed attachment point 101, the braid 9 does not move longitudinally relative to the retrieval device 3.

The opposite end of braid 9 is welded, bonded, or otherwise adhered to slidable collar 108. In the implementations shown, the slidable collar 108 is slidably connected to the retrieval device 3 by virtue of its annular shape, which extends circumferentially around the retrieval device 3. The slidable collar 108 slides longitudinally along the retrieval device 3 as braid 9 is expanded and collapsed. The slidable collar 108 can be positioned distally to the fixed attachment point 101 (a distal position), as shown in FIGS. 1A-1C, or the slidable collar 108 can be positioned proximally to the fixed attachment point 101 (a proximal position). In some implementations, slidable collar 108 or fixed attachment point 101 can include a marker that can be viewed using imaging modalities during a procedure. For example, the slidable collar 108 or fixed attachment point 101 can include a fluorescent or radiopaque label.

The braid 9 is composed of multiple strands of wire. The braid 9 takes an elliptical or a spindle shape when expanded, having a maximum diameter dmax at or near the center of the braid 9 and narrowing as the braid approaches the fixed attachment point 101 and the slidable collar 108. The wires are formed of a shape memory material such as, but not limited to, shape memory polymers or shape memory metals (e.g., nitinol). The braid 9 has a baseline shape memory of the collapsed configuration, which forms a cylindrical structure around the retrieval device 3, as shown in FIG. 1A. In the activated, expanded configuration, the braid 9 has a tendency to relax toward the collapsed configuration.

When the practitioner is pulling a thrombus or plaque proximally toward aspiration catheter 106 using braided assembly 102, the braid 9 encounters distally oriented drag forces that are strongest along the widest portions (for example, the central region of the braid adjacent dmax). These drag forces resist the proximally oriented pulling force exerted by the practitioner. The distal end of braid 9 at slidable collar 108 will encounter less drag force while being pulled proximally because the radial force it exerts on the radially adjacent vasculature or thrombus is small, negligible, or non-existent. If the braid is not properly designed, the sliding collar 108 and distal end of the braid 9 will invert into the wider, central regions of the braid 9. Inversion during the procedure can be prevented by optimizing factors such as the pic count (crosses per inch), the wire diameter, the number of wires, and the ply of the braid (sets of overlapping braids). Higher pic counts increase flexibility, while lower pic counts increase longitudinal stiffness. Likewise, a braid with more than one ply (multiple sets of braids nested within each other), will be stiffer than a single-ply braid. Braids can be one-ply, two-ply, three-ply, or more. Braids with more wires will be stiffer than those with fewer wires, and braids with wider diameter wires will be stiffer than those with narrow diameter wires. Wires of varying diameters can be used within the same braid 9.

The design of the braided assemblies 102 disclosed herein may vary based on whether the device 1 is intended for an arterial procedure or for a venous procedure, since the procedure site will be wider in a venous setting. For example, a braid 9 designed for a venous application may have a dmax of from about 0.8 inches to 1.2 inches, including about 0.8 inches, about 0.9 inches, about 1.0 inch, about 1.1 inches, and about 1.2 inches. For venous applications, a braid 9 may have a wire diameter range from about 0.005 inches to about 0.02 inches, including 0.005 inches, 0.0075 inches, 0.01 inches, 0.0125 inches, 0.015 inches, 0.0175 inches, and 0.02 inches. Different wires of the braid 9 may have different diameters, or they may have the same diameter. In some venous implementations, the diameters of the wires of the braid 9 are 0.01 inches, 0.0125 inches, and/or 0.015 inches. Two-ply braids can utilize smaller wire diameters without sacrificing the radial force that can be applied. The pic count can be from 2 to 6 for venous applications. In some implementations used in venous applications, the pic count is 3, 4, or 5. The number of wires per braid for a venous application can be anywhere from 8 to 40, including 8, 16, 24, 32, and 40.

Braids for venous applications were tested using a selection of the above listed venous application parameters. End points included the expansion force and the radial outward force applied by the braid to the inner surface of a tubing that simulates a vein (the tubing having an inner diameter of 24 millimeters). The expansion force is the force required to open the braid, as applied to the activation wire. The data is shown below in Table 1.

TABLE 1 Prototype testing for braids used in venous applications Wire Maximum Radial Outward Diameter Braid OD Force in 24 mm Expansion Prototype Braid Ply (Inches) # of Wires (inches) ID tube (N) force (N) A Double 0.008 16 per ply 1.0 4.4 2.5 (32 total) B Double 0.010 16 per ply 1.0 5.5-6.6 6 (32 total) C Single 0.0125 24 1.0 8.6-9.9 10

For arterial applications, the braid 9 can have dmax of from about 0.1 inches to about 0.4, including about 0.1 inches, about 0.12 inches, about 0.14 inches, about 0.18 inches, about 0.2 inches, about 0.22 inches, about 0.24 inches, about 0.28 inches, about 0.3 inches, about 0.32 inches, about 0.34 inches, about 0.36 inches, about 0.38 inches and about 0.4 inches. For example, the braid 9 can have a dmax of about 0.28 inches, 0.3 inches, or 0.31 inches. The diameter of the wires of the braid 9 for an arterial application can range from about 0.001 inches to about 0.007 inches, including about 0.001 inches, about 0.002 inches, about 0.003 inches, about 0.004 inches, about 0.005 inches, about 0.006 inches, and about 0.007 inches. Different wires of the braid 9 may have different diameters, or they may have the same diameter. In some arterial implementations, the diameters of the wires of braid 9 are 0.003 inches, 0.004 inches and/or 0.005 inches. Two-ply braids can utilize smaller wire diameters without sacrificing the radial force that can be applied. The pic count can be from 5 to 30 for arterial applications, including a pic count of 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 117, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 and 30. In some implementations used in arterial applications, the pic count is 10, 12, or 15. The number of wires per braid 9 for an arterial application can be anywhere from 8 to 54, including 8, 16, 24, 32, 40, 48, and 54. In some implementations, the number of wires per braid 9 for an arterial application is 26, 24, or 30.

Braids for arterial applications were tested using a selection of the above listed arterial application parameters. End points included the radial outward force applied by the braid to the inner surface of a tubing (the tubing having an inner diameter of 6 millimeters), and the proximal force needed to pull the braid through a restriction in the tubing (the inner diameter of the restriction being 4 millimeters). The tubing and the restriction simulate an artery and a thrombus/plaque, respectively. Favorable prototypes give a high radial outward force without requiring excessive force to pull the braid through the restriction. The data is shown below in Table 2. All braids tested were one-ply.

TABLE 2 Prototype testing for braids used in arterial applications Radial Profile Outward Force to pull (Distal Force applied through 4 mm Diameter bond Maximum to 6 mm I.D. ID Wire Pic # of OD) Braid OD tubing Restriction Prototype (inches) count Wires (inches) (inches) (Newtons) (Newtons) A 0.004 10 16 0.050 0.28 0.8 1.8 B 0.004 15 24 0.053 0.28 1.0 2.8 C 0.005 10 16 0.054 0.31 1.5 3.2 D 0.005 10 24 0.058 0.31 1.6 4.1 E 0.006 10 16 0.060 0.31 1.7 4.4 F 0.006 12 16 0.063 0.30 1.8 4.6 G 0.002 24 48 0.073 0.31 0.8 1.9 H 0.003 24 48 0.078 0.31 1.8 3.5 I 0.004 12 24 0.054 0.31 1.9 2.6

The activation wire 105 extends through the lumen of the retrieval device 3, exits the retrieval device 3 at exit point 11, and extends distally along the exterior surface of the retrieval device 3. The distal end 13 of the activation wire 105 is attached to slidable collar 108. As such, the activation wire 105 is able to control the expansion and collapse of the braid 9 via the slidable collar 108. The distance between exit point 11 and slidable collar 108 affects the length that the slidable collar can be pulled along retrieval device 3 to open the braided assembly 102. If it is too close to slidable collar, the braided assembly 102 will not be able to open fully. As such, exit point 11 should be positioned proximally far enough from the unexpanded position of slidable collar 108 to enable the braided assembly 102 to open to its maximum outer diameter. FIG. 1C shows the implementation of FIGS. 1A and 1B without braid 9 to facilitate viewing the activation wire 105 and the activation wire exit point 11. FIG. 1D is a cross sectional view of activation wire 105 in retrieval device 3, taken at line A-A of FIG. 1C. The internal positioning of the proximal regions of the activation wire 105 (within retrieval device 3) is advantageous in that no friction or bulk is added by the system that controls expansion of the braided assembly 102.

The proximal region of activation wire 105 (not shown) may be tensioned and released to control the expansion and collapse of the braided assembly 102 via movement of slidable collar 108. Under tension, the activation wire 105 moves proximally within the lumen of the retrieval device 3 as it translates the tension from the proximal region of the activation wire 105 to the braided assembly 102. In implementations where the slidable collar 108 is in the distal position (as shown), the exit point 11 of the activation wire is located proximally to the slidable collar 108. The exit point 11 can be, for example, a portal in the sidewall of retrieval device 3. Use of a slidable collar 108 to expand the braided assembly 102 is advantageous because the distal end of the braided assembly 102 can be moved while the distal region 5 of the retrieval device 3 maintains a constant position within the vasculature. Maintaining a constant position of the distal region 5 of retrieval device 3 is advantageous because sliding proximal/distal movement of the distal region 5 within the vessel can result in vessel damage or perforation.

In implementations where the slidable collar 108 is in the proximal position relative to the fixed attachment point (not shown), the activation wire 105 extends distally past the slidable collar 108 inside the retrieval device 3, exits the retrieval device 3 at exit point 11, then doubles back and extends along the exterior surface of the retrieval device 3 to attach to the proximally located slidable collar 108. The exit point 11 can be a portal in the sidewall of the retrieval device as described above, or the exit point 11 can be the distal end 107 of the retrieval device 3.

Retrieval device 3 can include a proximal hypotube 100 and a distal support tube 104, as shown in FIG. 1C. In some implementations, the hypotube 100 extends through the support tube 104. However, the distal region can be made more flexible by attaching the proximal end of the distal support tube 104 to the distal end 17 of the proximal hypotube 100 (for example, by adhesive bonding, heat bonding, or welding processes). The fixed attachment point 101 of the braided assembly 102 can be located on distal support tube 104 and the slidable collar 108 can extend around the distal support tube 104, such that the braided assembly 102 is positioned over and around the distal support tube 104. The braided assembly 102 can alternatively be positioned only partially over the distal support tube (i.e., one of the fixed attachment point 101 or the slidable collar 108 is attached to the proximal hypotube 100, and the other of the fixed attachment point or the slidable collar 108 is attached to the distal support tube 104). In some implementations, the support tube 104 serves to increase the overall diameter of the retrieval device 3, for example, to accommodate a larger diameter braid and to encapsulate the guidewire tip 103. The distal support tube 104 can also provide a lower friction surface for movement of the slidable collar 108 than the proximal hypotube 100 would provide.

In some implementations, distal support tube 104 has greater flexibility than the proximal hypotube 100. For example, the distal support tube 104 can be made of a polymer material, while the proximal hypotube 100 is made of a more rigid metal material. In some implementations, the proximal hypotube 100 is constructed from metal hypodermic needle tubing. The hypotube 100 can be up to 50 times stiffer than the support tube 104. There are several advantages to having a distal support tube 104 with greater flexibility than proximal hypotube 100. The greater flexibility of the support tube 104 enables a gradual transition in flexibility between the hypotube 100 and the guidewire tip 103. In some scenarios, the greater flexibility of the distal support tube 104 can facilitate movement of the braided assembly 102 through a tortuous thrombus. The greater flexibility can promote kink resistance. The greater flexibility of the distal support tube 104 can also facilitate the introduction of a portal or exit point 11 during the production of the device. The higher rigidity of the hypotube 100 (as compared to support tube 104) is important because it allows the retrieval device 3 to be pushed through the vasculature. The rigidity of hypotube 100 also helps to ensure that the braided assembly 102 can be pushed through a thrombus or plaque.

On the proximal end, the activation wire 105 can be attached to a tensioning element (not shown) that allows the activation wire 105 to be moved forward or retracted backward within the retrieval device 3. Applying tension to the activation wire 105 causes the slidable collar 108 to move and causes the braided assembly 102 to expand to a diameter of the practitioner's choosing. Similarly, releasing tension on the activation wire 105 allows the braided assembly 102 to relax into the collapsed, baseline configuration.

In some implementations, such as the one shown in FIG. 2, the device includes a proximal handle 128. The handle 128 is coupled to a proximal end of retrieval device 3. The tensioning element is a knob 129 that is coupled to the proximal end of activation wire 105 on the inside of the handle. Actuation of the knob 129 in one direction causes the activation wire 105 to be tensioned (expanding the braided assembly), and actuation of the knob 129 in the opposite direction releases tension on the activation wire 105 (collapsing the braided assembly). In other implementations, the tensioning element can include a slider, ratcheting mechanism, or lever.

In some implementations, aspiration catheter 106 terminates in an adapter, such as adapter 204 shown in FIG. 13. The adapter 204 facilitates the connection of aspiration tubing 203, which can be connected to a vacuum system such as shown in FIG. 8 for removal of the clot or emboli. In some exemplary procedures, the distal end of retrieval device 3 is inserted axially through into the proximal end of adapter 204 (where shown using the arrow in FIG. 13). The retrieval device 3 is slid through the adapter 204 and subsequently through the aspiration catheter 106 until handle 128 abuts the proximal end of adapter 204.

Another implementation of a proximal handle 128 is shown in FIGS. 7A-7C. The handle 128 of FIGS. 7A-7C is advantageous in that it enables a practitioner to lock the braided assembly 102 at a fixed outer diameter. This can be useful, for example, when pushing and pulling the device through a thrombus. As shown in FIG. 7A, proximal handle 128 is coupled to a proximal end of retrieval device 3. Activation wire 105 extends proximally past the proximal end retrieval device 3 and into proximal handle 128. Strain relief section 139 is formed of a flexible material that prevents kinking of the retrieval device 3 just distal to the handle 128. Proximal handle 128 also includes a tensioning element in the form of locking slider 136, which slides proximally and distally within groove 138 and can be locked in place to secure the outer diameter of the braided assembly 102 during a procedure. The underside of locking slider 136 and groove 138 is shown in FIG. 7B, and a cross sectional view of locking slider and groove 138 is shown in FIG. 7C. Locking slider 136 includes a sliding portion 146 and a lock button 148. As seen in FIG. 7B, downward pointing teeth 140 extend downward from the inner surface 133 of the outer casing 135 of handle 128, from a position adjacent the groove 138. The lock button 148 includes an exterior portion 141 with a textured gripping surface. The lock button 148 extends downward through sliding portion 146, and includes an interior portion 137. The interior portion 137 of the lock button 148 extends away from the exterior portion 141 of lock button 148 in a direction that is perpendicular to the longitudinal axis A-A of the locking slider 136. Interior portion 137 includes upward facing teeth 142 that are configured to engage with the downward facing teeth 140 of the outer casing 135 of the handle 136. Spring 150, which is vertically positioned within slider 146, beneath the exterior surface 141 of lock button 148, exerts an upward force on lock button 148 to hold the upward facing teeth 142 in a locked configuration with the downward facing teeth 140 of the outer casing 135. When lock button 148 is compressed, the spring 150 is compressed and the teeth 140, 142 disengage. With the lock button 148 pressed and the teeth 140, 142 disengaged, proximal or distal force can be applied to sliding portion 146 to move the locking slider 136 within the groove 138. An interior portion 144 of the sliding portion 146 grips the activation wire 105. As the locking slider 136 is moved within groove 138, the activation wire 105 is moved proximally or distally to affect the expansion or allow the collapse of the braided assembly 102.

Conventional thrombectomy devices utilize shape memory elements with a baseline expanded configuration. These conventional devices risk inadvertent overexpansion and damage to the vessel. Furthermore, conventional devices are often restrained by a bulky overlying sheath, which is pulled back to allow the device to self-expand.

Advantageously, using a device with a shape memory of the collapsed position reduces the risk of overexpansion and injury during self-expansion. Self-collapse also allows the device to be restrained using the low-profile activation wire system described herein. An additional advantage is the ability to expand the braided assembly to various diameters to precisely custom fit the size of the vessel. This can be especially useful if the size of the vessel is different than originally anticipated. The level of grip between the braid 9 and the surrounding thrombus can also be customized as needed by applying different levels of tension to the activation wire 105. For example, the practitioner may apply a first level of tension to deploy the braided assembly 102 to a first expanded outer diameter to contact the thrombus. If the force between the thrombus and the braid 9 is not enough to pull the thrombus toward the aspiration catheter 106, the practitioner can widen the braid 9 to a second expanded outer diameter by applying a greater second level of tension to the activation wire 105. This widened diameter provides a greater contact force between the thrombus and the braid 9, such that the thrombus can be more easily pulled toward aspiration catheter 106.

FIGS. 3A-3D show an additional implementation of a thrombectomy device having a braided assembly 19 with multiple braided sections 111, 112. The elongated nature of this implementation facilitates the capture and retrieval of long thrombi. As shown in FIG. 3A and FIG. 3B, ach of the braided sections 111, 112 is attached to and extends around the distal region 22 of retrieval device 21. The braided assembly 19 includes multiple sliding collars 23, 25 and a fixed attachment point 27. Proximal braided section 111 is attached to and extends between the fixed attachment point 27 and the proximal slidable collar 23, where it is welded, bonded, or otherwise adhered at a central sliding attachment point 29. Distal braided section 112 is attached to and extends between the proximal slidable collar 23 and the distal slidable collar 25. In some implementations, the braided sections are formed by constraining one larger braid with the proximal slidable collar 23. In other implementations, each braided section is formed from a separate braid (such that each of the proximal and distal braided assemblies are separately fixedly attached to proximal slidable collar 23). In some implementations, the slidable collars 23, 25 can be positioned distally to the fixed attachment point 27, as illustrated in FIG. 3A. In other implementations, the slidable collars can be positioned proximally to the fixed attachment point (not shown). Though illustrated with two braided sections 111, 112, other implementations of the braided assembly 19 could include more than two braided sections and more than two slidable collars.

FIG. 3C shows the thrombectomy device of FIGS. 3A and 3B without the braided assembly 19. Retrieval device 21 has a hypotube 131 fixedly attached to a support tube 130. A single activation wire 132 extends through hypotube 131 and support tube 130 to an exit point 134 positioned on the support tube 130. From there, it travels along the outer surface of support tube 130, running beneath proximal sliding collar 23 to attach to distal sliding collar 25. Cross sectional views shown in FIG. 3D, FIG. 3E, FIG. 3F, and FIG. 3G show the radial position of activation wire 132 with respect to hypotube 131, the support tube 130, and the guidewire tip 103 at various axial locations along the thrombectomy device shown in FIG. 3C. The activation wire 132 is utilized to control expansion of the braided assembly via connection to the distal sliding collar 25. In other implementations, the activation wire 132 can be attached to the proximal sliding collar 23. Proximal movement of the proximal slidable collar 23 or the distal slidable collar 25 by the activation wire generates a force on the other of the two slidable collars, such that the two braided sections 111, 112 are expanded (or partially expanded) in unison. As described above, the braids are formed of a shape memory material with a bias toward the collapsed configuration, so that tensioning the activation wire enables multiple levels of expansion.

FIG. 4 shows an additional implementation with multiple, separately expandable braided assemblies 37, 39. The braided assemblies 37, 39 are spaced from each other along the distal region 32 of retrieval device 31. The proximal braided assembly 37 includes braided section 113 that extends between a fixed attachment point 33 and a slidable collar 115. The distal braided assembly 39 includes braided section 114 that extends between a fixed attachment point 35 and a slidable collar 116. Each braided assembly is controlled by a separate activation wire, such that each braided assembly can be individually controlled. Each activation wire exits the retrieval device 31 from an exit point beneath the individual braid and attaches to the individual slidable collar (not shown). The multiple activation wires can travel through the same lumen in retrieval device 31, or they could have individual lumens. Depending upon the positioning of the slidable collars in relation to the fixed attachment points, in some implementations, each additional activation wire can travel through the same lumen and exit the retrieval device at the same portal, or at different portals. In some implementations, one or more activation wires can exit from the distal end of the retrieval device 31.

As with the previously described implementations, the braids of the implementation shown in FIG. 4 are formed of a shape memory material with a bias toward the collapsed configuration, such that tensioning the activation wire enables deployment of the braid to a range of diameters. Each braided assembly is deployable to a partially expanded configuration by placing a first level of tension in the attached activation wire, or to a fully expanded configuration by placing a second, greater level of tension into the activation wire. Thus, when multiple activation wires and braided assemblies are used, a first braided assembly can be deployed to a partially expanded state while a second braided assembly is deployed in a fully expanded state. In some scenarios, it may be advantageous for one braided assembly to be fully collapsed while another braided assembly is either partially or fully expanded. This can be advantageous, for example, when pulling a longer thrombus into the aspiration catheter 106. The proximal braided section 113 can be collapsed as it enters the aspiration catheter, prior to the distal braided section 114 which is still outside of the aspiration catheter.

In some implementations, braids of separate braided sections or separate braided assemblies can have different properties, such as different maximum expanded diameters, different wire sizes, different wire densities, different numbers of wires, etc. These properties can vary depending upon the positioning of the braided section or the braided assembly along the retrieval device. For example, the distal braided section or braided assembly might have a larger expanded diameter to better pull back against the thrombus, while the proximal braided section(s) or braided assembly(s) might be less dense and stronger to better engage the middle of the thrombus.

FIGS. 5A-5C show an implementation of the thrombectomy device that enables use with a guidewire, such that a practitioner can remove and reinsert the device to the same anatomic position multiple times (for example, to clean the device during the procedure). FIG. 5A shows aspiration catheter 127, retrieval device 121, guidewire tubing 118, braided assembly 123 (in the collapsed configuration), and guidewire 45. Guidewire tubing 118 is positioned around the distal region 61 of retrieval device 121. The guidewire tubing 118 is shorter than the retrieval device 121 in the longitudinal direction, such that the guidewire 45 leaves the guidewire tubing 118 at the proximal guidewire exit 117 and extends alongside retrieval device in a proximal direction. FIG. 5B shows the implementation of FIG. 5A with the braided assembly 123 in an expanded state. As shown in the cross section of FIG. 5C taken at line B-B of FIG. 5B, guidewire 45 extends through the first lumen 124 of the guidewire tubing 118. The guidewire 45 exits guidewire tubing 118 at distal guidewire exit 47. The guidewire tubing 118 can include a distal atraumatic tip 120. The guidewire tubing 118 can be formed, for example, of a polymer material. Retrieval device 121, including activation wire 125, extends through a second lumen 126 of the guidewire tubing 118. As described above, the activation wire 125 is connected on the proximal end to a tensioning element, extends through retrieval device 121 to an exit point, leaves the retrieval device 121 at the exit point (beneath the braid), and attaches at its distal end to the slidable distal collar 122 on the braided assembly 123. The exit point can be, for example, a tunnel through the sidewalls of the retrieval device 121 and the guidewire tubing 118 (i.e., a tunnel formed by a portal in the sidewall of the retrieval device 121 that is aligned/coaxial with a portal in the sidewall of the guidewire tubing 118). In use, the guidewire tubing 118 and the retrieval device 121 are introduced together over the previously placed vascular guidewire 45. Because the guidewire 45 is retained within the guidewire tubing 118, it is pulled at least partially to the side within the lumen of aspiration catheter 127 and can move without interfering with activation wire 125. The guidewire tubing 118 and the retrieval device 121 keep the activation wire 125 and the guidewire 45 moving in an axial direction, independently from one another, using a low-profile and low-friction design. Once in position, the braided assembly 123 is expanded and the proximal end of the aspiration catheter 127 is connected to a vacuum source. The braided assembly 123 is expanded and then retracted back toward the aspiration catheter 127, pulling the clot with it and breaking it into small pieces.

Methods of performing thrombectomy procedures are also disclosed herein. An example method is illustrated in FIGS. 6A-6F. FIG. 6A illustrates thrombus 49 occluding vessel 51. Distal end of aspiration catheter 53 is advanced through the vasculature to an area proximal to the thrombus 49, as shown in FIG. 6B. The distal end of retrieval device 55 carrying braided assembly 57 is advanced out the distal end of the aspiration catheter 53 and through thrombus 49, such that the braided assembly 57 is distal to thrombus 49, as shown in FIG. 6C. The practitioner then places tension in the activation wire housed inside the retrieval device 55, thereby moving the activation wire longitudinally within the lumen of the retrieval device and moving the slidable collar of the braided assembly longitudinally over the exterior surface of the retrieval device. Movement of the slidable collar via the activation wire causes braided assembly 57 to expand to the diameter of the practitioner's choosing. Should the practitioner wish to alter the level of expansion during the procedure (i.e., change the maximum diameter d of the braided assembly 57), this is made possible by altering the level of tension in the activation wire, which again moves the activation wire within the retrieval device and moves the slidable collar, as described above. Advantageously, the distal end of the retrieval device 55 maintains a stationary position as the braided assembly is expanded to the optimal diameter. Maintaining a constant position of the distal end of retrieval device 55 is advantageous because sliding proximal/distal movement of the distal end within the vessel can result in vessel damage or perforation.

FIG. 6D shows the braided assembly 57 in an expanded configuration, sized to fit the vessel 51. The practitioner then pulls the retrieval device 55 proximally and contacts the thrombus 49 with the braided assembly 57, as shown in FIG. 6E. The thrombus 49 and braided assembly 57 are pulled proximally toward aspiration catheter 53. The aspiration catheter 53 can be connected to an external vacuum source (not shown), which enables the aspiration of the thrombus 49 into the distal end of the aspiration catheter 53. The aspiration catheter 53 is then retracted proximally, as illustrated in FIG. 6F, and removed from the body.

The ability to open the braided assembly to a range of different diameters is useful to thrombectomy procedures for multiple reasons and in multiple scenarios. The ability to custom fit the braid to a particular vessel during the procedure is preferable over introducing a braid that expands to a predetermined size, then discovering mid-procedure that it is either too small to grip the thrombus or that it is too large and has damaged the vessel. As another exemplary advantage, the level of grip between the braid and the thrombus can be optimized mid-procedure. For example, the practitioner may apply a first level of tension to the activation wire to deploy the braided assembly to a first expanded outer diameter to contact the thrombus. If the force between the thrombus and the braid is not sufficient to pull the thrombus toward the aspiration catheter, the practitioner can widen the braid to a second expanded outer diameter by applying a greater second level of tension to the activation wire. This widened diameter increases the contact force between the thrombus and the braid, such that the thrombus is more easily pulled toward aspiration catheter.

The methods can also be performed using a guidewire. For example, the guidewire can be positioned distal to the thrombus prior to advancing the distal end of the retrieval device. The retrieval device extends at least partially through a lumen of the guidewire tubing, such as in the implementation of FIGS. 5A-5C. Together, the retrieval device and guidewire tubing are advanced over the guidewire and toward the thrombus. The guidewire extends through a separate lumen of the guidewire tubing than the retrieval device and activation wire. Once positioned, the activation wire is moved longitudinally within the retrieval device to expand the braided assembly.

Long thrombi can be addressed using braided assemblies with multiple braided sections such as the implementation shown in FIG. 3. Movement of the slidable collar results in expansion of more than one of the braided sections, resulting in a relatively long braided assembly. In some implementations a device with multiple, separately expandable braided assemblies, such as the one shown in FIG. 4, can be used to treat long thrombi. With separately expandable braided assemblies, as the thrombus is drawn proximally closer to the distal end of the aspiration catheter, the proximally positioned braided assembly collapses from a first expanded outer diameter to the collapsed diameter (or to a narrower second expanded outer diameter). The distally positioned braided assembly maintains an expanded outer diameter that is greater than the outer diameter of the proximally positioned braided assembly until it too is pulled into the aspiration catheter.

The aspiration systems and methods disclosed herein are configured to control blood loss during thrombus removal. An example aspiration system 201 is shown in FIG. 8. The aspiration system 201 includes an aspiration tubing 203, which extends from adapter 204 shown in FIG. 13. An aspiration lumen 216 extends from (and includes) the lumen of the aspiration catheter 106 and the lumen of the aspiration tubing 203 leading to the receptacle 205. The aspiration tubing 203 is coupled to a receptacle 205 for collecting liquid aspirated by the aspiration catheter 106. In other implementations, aspiration catheter 106 can be directly coupled to receptacle 205 for collecting liquid aspirated by the aspiration catheter 106. The aspiration tubing 203 (or aspiration catheter 106) creates a fluidic seal with the receptacle 205, and a vacuum line 207 is also fluidically coupled to and sealed with receptacle 205. The vacuum line 207 is fluidically coupled to a vacuum pump 209.

The aspiration tubing 203 is coupled to one or more sensors 211. (If aspiration catheter 106 is directly attached to receptacle 205, the sensors 211 are coupled to the catheter 106.) A sensor 211 is configured to measure a flow parameter associated with a liquid within the lumen of the aspiration tubing 203 (such as the flow rate, for example). The sensor 211 is operably connected to a vacuum controller 213, for example, via wiring 215 to 4-pin connector 217 (or any suitable connector). The vacuum controller 213 is also operably coupled to a regulator 219, for example, via wiring 220, and regulator 219 is coupled to vacuum line 207. The regulator 219 is configured to adjust the vacuum pressure within the vacuum line 207.

When the vacuum controller 213 receives the flow parameter from sensor 211, it compares the flow parameter to a desired target range and sends an automatic control signal to the regulator 219, based on the comparison of the flow parameter to the target range. The automatic control signal causes the regulator 219 to adjust the vacuum pressure within vacuum line 207. For example, the automatic control signal can cause the regulator 219 to reduce the vacuum pressure upon a determination that the flow parameter is above an upper limit of the target range, or to decrease the vacuum pressure upon a determination that the flow parameter is below a lower limit of the target range. The vacuum controller 213 and the regulator 219 can optionally communicate in a feedback loop to regulate the vacuum pressure, wherein the vacuum controller 213 communicates a control signal to the regulator 219 and the regulator 219 communicates the current vacuum pressure back to the vacuum controller 213. In one example, communication from the regulator 219 to the vacuum controller 213 can be accomplished via wiring 221. These components and operations will be discussed in greater detail, below.

The vacuum pump 209 can be a standard medical suction pump conventionally used in hospitals, outpatient surgery centers, and clinical practices. As one example, the vacuum pump 209 can be a Basic Suction Pump (Medela AG, Baar, Switzerland), which has piston-cylinder based drive unit and mechanical overflow to protect the pump. The Medela Basic Suction pump has a max flow rate of 300 mL/min and a maximum vacuum of 90 kPa below ambient pressure. However, the make or model of vacuum pump 209 is not limited—it can be any type available in clinical settings. The vacuum pump 209 can be provided by the user, or it can be provided as part of a kit with some or all of the other components shown in FIG. 8.

The aspiration tubing 203 is coupled to the receptacle 205 at an intake port 223, and the vacuum line 207 is coupled to the receptacle 205 at the vacuum port 225. The aspiration tubing 203, receptacle 205, and vacuum line 207 can be any make or model. The sizes and materials can be adapted to suit the needs of the particular procedure. These components can be provided by the user, or they can be provided as part of a kit with some or all of the other components shown in FIG. 8. The components shown on the right side of the arrows in FIG. 8, including the aspiration tubing 203, the flow sensor 211, the receptacle 205 and the vacuum line 207 can all optionally be disposable to reduce the need for sterilization between procedures. A connector 227 can be placed on the vacuum line 207 to enable connection of the disposal portion 207a of the vacuum line with a reusable portion 207b of the vacuum line.

As discussed above, regulator 219 communicates with vacuum controller 213 to control the pressure in vacuum line 207. In one example, the regulator is an ITC 2090. As one example, the regulator 219 include can have a valve that opens the vacuum line 207 to the atmosphere, thus decreasing the vacuum pressure by venting the system. As another example, regulation of flow can be achieved by incorporating an adjustable flow valve, which may widen or narrow the vacuum line 207b to alter the flow capacity (i.e., direct flow control). Notably, handling flow adjustments on the vacuum side (i.e., to the left of the arrow in FIG. 8) reduces the need to clean the flow handling components. This is an advantage over systems with components that physically restrict blood flow within the aspiration tubing.

The flow sensor 211 can be in direct contact with the liquid in the aspiration tubing 203, or it can be configured for contactless sensing. For example, in some implementations, the flow sensor 211 is a paddle-wheel style sensor positioned within the aspiration lumen 216. A paddle-wheel style sensor sends turn frequency measurements to the vacuum controller 213, which determines the flow rate accordingly. Alternatively, the flow sensor 211 can be an ultrasonic sensor, a laser-based sensor, an infrared sensor, or some other optical based sensor, measuring the flow parameters through the walls of aspiration tubing 203 without contacting the blood. These have the benefit of being reusable, but are typically costlier than a contact-based sensor. While a single sensor 211 is shown in FIG. 8, it is further possible to incorporate a plurality of sensors that measure at disparate points along a length of the aspiration tubing 203. In some examples, an interfacing filter can be positioned upstream from the flow sensor 211 to filter clots before they reach the sensor.

Adapter 204 shown in FIG. 13 facilitates the entry of the retrieval device 3 through proximal port 206 and into the lumen of the aspiration catheter 106. Adapter 204 also provides a fluidic coupling between the aspiration catheter 106 and vacuum system 201 (via aspiration tubing 203). Infusion port 208 allows for the introduction of saline or other infusion fluids. Adapter 204 houses an airtight valve that enables retrieval device 3 to be introduced through proximal port 206 without passing air into the adapter 204. However, the aspiration tubing 203 can include an air leak sensor 214, such as an optical sensor, to detect air passage in case of valve failure. In some implementations, the air leak sensor 214 is positioned proximal to the flow sensor 211 to detect air before it reaches the vacuum system. Alternatively, the air leak sensor 214 can be integral with the flow sensor 211.

The air leak sensor 214 can communicate a leak signal to the vacuum controller 213, the regulator 219, or directly to the vacuum pump 209, at which point the vacuum controller 213, the regulator 219, or the pump 209 slows or stops the vacuum flow while the air leak is addressed, reducing blood loss. In some implementations, there is a leak detection delay during initialization of the vacuum. The leak detection delay prevents the aspiration of the initial air in the tube—otherwise, the air leak sensor may detect it as a leak.

As shown in FIG. 8, the flow sensor 211 can be in communication with an indicator 212. The indicator 212 can be configured to inform the user of a characteristic of the flow parameter or flow rate. For example, the indicator 212 can be an LED light or an LED light panel, with variations in luminosity or flashing frequency that indicate the flow rate through the aspiration tubing 203. The indicator could alternatively be audible, or it could be a display on a user interface 229. The indicator 212 is shown positioned on the flow sensor 211, but in operation could be positioned anywhere within the system. The flow sensor 211 can communicate directly with the indicator 212, or via the vacuum controller 213.

The system provide for one or more manual override options, which may communicate a complete shut-off of the vacuum or aspiration flow, a scaled diminishing of the vacuum or aspiration flow, a reactivation of vacuum or aspiration flow, or a scaled increasing of the vacuum or aspiration flow. The manual commands are accepted at one or more manual inputs, such as, but not limited to, clamps, switches, buttons, sliders, knobs, pedals or a digital user interface. In some examples, a clamp 231 can be coupled to the aspiration tubing 203 to enable the practitioner to manually stop the flow of blood through the aspiration tubing 203, overriding the automated system. Alternatively or additionally, a manual override switch or button can communicate with the regulator 219 to fully open the valve to atmospheric pressure, thereby releasing the pressure in the vacuum line 207. As an alternative to a binary switch or button that fully releases the vacuum, sliders, knobs, or the like can be used to diminish or increase the vacuum force gradually. As another alternative, a foot pedal (not shown) can be activated to shut down or slow the flow either at the clamp 231, the regulator 219, or the pump 209 (or reactivate and increase the flow at any of those components). In some implementations, a manual override option can be provided at a user interface 229 (including manual or digital switches, sliders or knobs). Finally, the user has the option to turn the vacuum on and off at the vacuum pump 209, or gradually adjust its strength.

Triggering a manual override option can induce a first manual control signal to be sent from the manual input to the vacuum controller. The first manual control signal can cause the vacuum controller 213 to stop performing the step of comparing the flow parameter to the target range, or to stop the step of forming the automatic control signal, or to stop the step of sending the automatic control signal to the regulator. The vacuum controller 213 can instead send a second manual control signal to the regulator 219 based on the manual input (information from the first manual control signal). Alternatively, triggering a manual override option can send a manual control signal from the manual input directly to the regulator 219 to raise or lower the vacuum pressure in the vacuum line 207. Likewise, the manual input can be triggered to reactivate any or all of these processes.

In some implementations, the receptacle 205 can include a receptacle vent 210 in communication with the vacuum controller 213, the vacuum pump 209, the regulator 219, or with one or more of the manual inputs. Any one of the above-listed manual override actions can trigger a receptacle venting signal to be sent to the receptacle vent 210, directly or via the vacuum controller 213. The vent receives the receptacle venting signal and opens to equilibrate the pressure in the receptacle 205 with atmospheric pressure. This action eliminates residual pressure in the receptacle 205 that might otherwise cause the suction of additional blood after the manual override action. In some aspects, the venting signal may be a manual control signal sent by the vacuum controller 213 or regulator 219 upon activation of one or more manual inputs (for example, a manual command to override the vacuum system).

The clamp 231 can be coupled to tubing between the aspiration tubing 203 and the receptacle 205 and can be activated by a switch 233 for ease of use. The switch 233 can have an open configuration and a closed configuration. In the closed configuration, the switch tells the clamp 231 to close off the flow to the receptacle 205. In the open configuration, the switch 233 tells the clamp 231 to open the catheter 203 and allow blood to flow into receptacle 205. However, closure of clamp 231 can cause vacuum pressure to build up in the vacuum line 207. Opening the clamp 231 can thus cause a sudden surge and suction of blood. To avoid this, the switch 233 can be in operable communication with either the vacuum controller 213 or the regulator 219 (for example, via wiring 235). The shifting of switch 233 to the open configuration sends a surge signal to the regulator 219, either directly or via vacuum controller 213 as shown in FIG. 8. The surge signal causes the regulator to decrease the vacuum pressure in vacuum line 207, thereby reducing the surge of blood associated with opening the clamp 231. In some examples, the switch can be configured to cause a lowering of the vacuum pressure in the vacuum line 207 before releasing the clamp 231.

Some examples of the system include a user interface 229. The user interface 229 can optionally be a touch screen, or it can be in communication with a keyboard. Regardless, the user interface can be configured to accept manual input. The user interface 229 can be in communication with the vacuum controller 213 or with the regulator 219, and is configured to send manual control signals to the vacuum controller 213 or the regulator 219 responsive to the manual input. For example, the user can adjust the upper and lower limits of the target range and/or the time delay in triggering a vacuum change (for example, how long the flow rate is permitted to be at or above the upper limit before the vacuum pressure is decreased). The user interface can include a manual override button that allows the user to stop automated control and manually set the flow rate through the aspiration tubing 203. The user interface 229 can also include readouts to inform the user of the instantaneous flow rate through the aspiration tubing 203, and/or the total blood collected at receptacle 205.

Communication between the components of aspiration system 201 can take occur via any suitable communication link that facilitates data exchange between the components. Communication links can include wired, wireless, and optical links. Example communication links include, but are not limited to, a local area network (LAN), a wireless local area network (WLAN), a wide area network (WAN), a metropolitan area network (MAN), Ethernet, the internet, or any other wired, or wireless link such as WiFi, WiMax, 3G, 4G, or 5G. As shown in FIG. 8, the communication links can be formed of electrical or optical wires 215, 220, 221, 235, and 237. However, the presence of some wires in the drawing is not intended to indicate that those communication links, or any communication links, within the system must be hard-wired. Any of the communication links disclosed herein can be wired or wireless in nature.

The vacuum controller 213 can advantageously be a microprocessor that operates independently of a larger computer system. For example, vacuum controller 213 can be a complex instruction set microprocessor, a reduced instruction set microprocessor, a superscalar processor, an application specific integrated circuit, or a digital signal multiprocessor. The vacuum controller 213 is configured to measure frequency from the flow parameter received from sensor 211, and includes an analog to digital converter and a digital to analog converter. Power source 239 can be any suitable power source, and can be external to the vacuum controller 213 (such as a wall outlet) or internal to the vacuum controller 213 (such as a battery).

In some implementations, power sensors 240 can be included on the pump 209 and/or the vacuum controller 213 in order to synchronize the delivery of power between the two components. That is, when one of the two components (pump 209 or vacuum controller 213) is powered off, the power sensor 240 on the other of the two components detects the power change and is automatically powered off. Likewise, when one of the two components (pump 209 or vacuum controller 213) is powered on, the other is also automatically powered on.

With the basic structure of the aspiration system 201 being thusly disclosed, a greater appreciation of the construction and benefits of may be gained from the following discussion of the operation of the aspiration system 201 as shown in the flow chart at FIG. 9 and in reference to the diagram of FIG. 8. It is to be noted that this discussion is provided for illustrative purposes only. A method of controlling blood loss during thrombus removal is disclosed herein. The method includes first positioning an aspiration tubing 203 within the vascular system of a subject. The vacuum pump 209 is then initialized, or activated (either directly or via power sensor 240 which is in communication with the power supply to vacuum controller 213). The vacuum pump 209 is in fluid communication with the aspiration tubing 203. The method further includes initiating a flow of blood through an aspiration lumen 216 and measuring a flow parameter of the blood within the aspiration lumen 216 using a flow sensor 211. The method further includes receiving the flow parameter from flow sensor 211 at a vacuum controller 213. The vacuum controller 213 compares the flow parameter to a target range for the flow parameter and sends an automatic control signal to the vacuum regulator 219 based on a comparison of the flow parameter to the target range. The method further includes adjusting the vacuum pressure within the vacuum line 207 according to information stored in the automatic control signal.

In some example methods, activating a vacuum pump comprises activating the vacuum pump at full power, as shown in FIG. 9. Full vacuum power is fed to the regulator 219, which is regulated by the vacuum controller 213. When the flow exceeds the upper limit, the vacuum pump can be dropped off full power, and a finer level of intermediate control can be commanded via the regulator. The regulator can vent the system to atmospheric pressure to the extent necessary to accomplish the desired intermediate vacuum level.

The vacuum is imposed on the catheter 203 through the receptacle 205. The catheter 203 draws fluid from the patient. The flow is measured and a closed circuit loop is formed that provides controlling the desired flow with the amount of vacuum. When the flow drops below the lower limit, the vacuum controller 213 returns the vacuum pump 209 to full power and commands the regulator to fully close the system to atmospheric pressure.

For example, FIG. 10 shows a line graph of the flow rate in aspiration tubing 203. At initialization, the vacuum is increased to full power and flow rate reaches the first peak seen on the graph—the upper limit (uppermost dashed horizontal line). The vacuum controller 213 determines that the upper limit of the flow rate has been reached, and controller tells the regulator 219 to reduce the pressure in the vacuum line 207. The vacuum controller 213 continues to tell the regulator 219 to reduce vacuum pressure until the flow rate reaches the intermediate level (middle horizontal dashed peak). The flow rate continues at the intermediate level until it is reduced by the presence of a clot. The reduction of flow rate down to the lower limit (lowermost dashed horizontal line) causes the vacuum controller 213 to tell the regulator 219 to enable allow full vacuum power in the vacuum line 207, and the flow rate again reaches the upper limit.

Adjusting the vacuum pressure can be accomplished by decreasing the vacuum pressure upon a determination that the flow parameter is above an upper limit of the target range. In some examples, the upper limit is a flow rate of from 70 mL per minute to 130 mL per minute (including, for example, 70 mL per minute, 75 mL per minute, 80 mL per minute, 85 mL per minute, 90 mL per minute, 95 mL per minute, 100 mL per minute, 105 mL per minute, 110 mL per minute, 115 mL per minute, 120 mL per minute, 125 mL per minute, and 130 mL per minute).

In some example methods, the vacuum pressure is decreased until the measured flow parameter reaches an intermediate level flow rate of from 20 mL per minute to 50 mL per minute (including, for example, 20 mL per minute, 25 mL per minute, 30 mL per minute, 35 mL per minute, 40 mL per minute, 45 mL per minute, and 50 mL per minute).

Adjusting the vacuum pressure can be accomplished by increasing the vacuum pressure upon a determination that the flow parameter is below a lower limit of the target range. The lower limit can be, for example, from 0 mL per minute to 50 mL per minute (including, for example, 0 mL per minute, 10 mL per minute, 15 mL per minute, 20 mL per minute, 25 mL per minute, 30 mL per minute, 35 mL per minute, 40 mL per minute, 45 mL per minute, and 50 mL per minute).

In some implementations, decreasing or increasing the vacuum pressure can occur gradually, or in a stepwise manner, according to an aspiration program. This helps to reduce sudden surges and stops, giving the practitioner sufficient time to respond as necessary to sudden changes in flow rate. For example, FIG. 11, shows a line graph where flow rate is decreased in a step wise manner. At initialization, the vacuum is increased to full power and flow rate reaches the first peak seen on the graph—the upper limit of 100 mL per minute in this example (uppermost dashed horizontal line). The vacuum controller 213 determines that the upper limit of the flow rate has been reached, and vacuum controller 213 tells the regulator 219 to reduce the pressure in the vacuum line 207 to a first intermediate flow rate of 75 mL per minute (in this example). The vacuum controller 213 operates the regulator 219 at this first intermediate level for a specified time period and then tells the regulator to decrease the flow rate to a second intermediate level—50 mL per minute in this example. The vacuum controller 213 operates the regulator at this second intermediate level for a specified time period and then tells the regulator to decrease the flow rate to a third intermediate level—20 mL per minute in this example. The flow rate continues at the third intermediate level until it is reduced by the presence of a clot. The reduction of flow rate down to the lower limit (lowermost dashed horizontal line—5 mL per minute in this example) causes the vacuum controller 213 to tell the regulator 219 to enable allow full vacuum power in the vacuum line 207, and the flow rate again reaches the upper limit.

In some implementations, the durations of time in each of the steps of the aspiration program shown in FIG. 11 can be programmable via a manual input such as those described above. The user can set the duration of the “burst” (full vacuum power) and of each stepwise interval via a slider, a knob, a user interface, the software, or a combination thereof. The user can thus tailor the aspiration program to the procedural situation.

It should be appreciated that the logical operations described herein with respect to the various figures may be implemented (1) as a sequence of computer implemented acts or program modules (i.e., software) running on a computing device (e.g., the computing device described in FIG. 12), (2) as interconnected machine logic circuits or circuit modules (i.e., hardware) within the computing device and/or (3) a combination of software and hardware of the computing device. Thus, the logical operations discussed herein are not limited to any specific combination of hardware and software. The implementation is a matter of choice dependent on the performance and other requirements of the computing device. Accordingly, the logical operations described herein are referred to variously as operations, structural devices, acts, or modules. These operations, structural devices, acts and modules may be implemented in software, in firmware, in special purpose digital logic, and any combination thereof. It should also be appreciated that more or fewer operations may be performed than shown in the figures and described herein. These operations may also be performed in a different order than those described herein.

Referring to FIG. 12, an example computing device 900 upon which implementations of the invention may be implemented is illustrated. For example, the vacuum controller 213 may each be implemented as a computing device, such as computing device 900. It should be understood that the example computing device 900 is only one example of a suitable computing environment upon which implementations of the invention may be implemented. Optionally, the computing device 900 can be a well-known computing system including, but not limited to, personal computers, servers, handheld or laptop devices, multiprocessor systems, microprocessor-based systems, network personal computers (PCs), minicomputers, mainframe computers, embedded systems, and/or distributed computing environments including a plurality of any of the above systems or devices. Distributed computing environments enable remote computing devices, which are connected to a communication network or other data transmission medium, to perform various tasks. In the distributed computing environment, the program modules, applications, and other data may be stored on local and/or remote computer storage media.

In an implementation, the computing device 900 may comprise two or more computers in communication with each other that collaborate to perform a task. For example, but not by way of limitation, an application may be partitioned in such a way as to permit concurrent and/or parallel processing of the instructions of the application. Alternatively, the data processed by the application may be partitioned in such a way as to permit concurrent and/or parallel processing of different portions of a data set by the two or more computers. In an implementation, virtualization software may be employed by the computing device 900 to provide the functionality of a number of servers that is not directly bound to the number of computers in the computing device 900. For example, virtualization software may provide twenty virtual servers on four physical computers. In an implementation, the functionality disclosed above may be provided by executing the application and/or applications in a cloud computing environment. Cloud computing may comprise providing computing services via a network connection using dynamically scalable computing resources. Cloud computing may be supported, at least in part, by virtualization software. A cloud computing environment may be established by an enterprise and/or may be hired on an as-needed basis from a third party provider. Some cloud computing environments may comprise cloud computing resources owned and operated by the enterprise as well as cloud computing resources hired and/or leased from a third party provider.

In its most basic configuration, computing device 900 typically includes at least one processing unit 920 and system memory 930. Depending on the exact configuration and type of computing device, system memory 930 may be volatile (such as random access memory (RAM)), non-volatile (such as read-only memory (ROM), flash memory, etc.), or some combination of the two. This most basic configuration is illustrated in FIG. 12 by dashed line 910. The processing unit 920 may be a standard programmable processor that performs arithmetic and logic operations necessary for operation of the computing device 900. While only one processing unit 920 is shown, multiple processors may be present. Thus, while instructions may be discussed as executed by a processor, the instructions may be executed simultaneously, serially, or otherwise executed by one or multiple processors. The computing device 900 may also include a bus or other communication mechanism for communicating information among various components of the computing device 900.

Computing device 900 may have additional features/functionality. For example, computing device 900 may include additional storage such as removable storage 940 and non-removable storage 950 including, but not limited to, magnetic or optical disks or tapes. Computing device 900 may also contain network connection(s) 980 that allow the device to communicate with other devices such as over the communication pathways described herein. The network connection(s) 980 may take the form of modems, modem banks, Ethernet cards, universal serial bus (USB) interface cards, serial interfaces, token ring cards, fiber distributed data interface (FDDI) cards, wireless local area network (WLAN) cards, radio transceiver cards such as code division multiple access (CDMA), global system for mobile communications (GSM), long-term evolution (LTE), worldwide interoperability for microwave access (WiMAX), and/or other air interface protocol radio transceiver cards, and other well-known network devices. Computing device 900 may also have input device(s) 970 such as a keyboards, keypads, switches, dials, mice, track balls, touch screens, voice recognizers, card readers, paper tape readers, or other well-known input devices. Output device(s) 960 such as a printers, video monitors, liquid crystal displays (LCDs), touch screen displays, displays, speakers, etc. may also be included. The additional devices may be connected to the bus in order to facilitate communication of data among the components of the computing device 900. All these devices are well known in the art and need not be discussed at length here.

The processing unit 920 may be configured to execute program code encoded in tangible, computer-readable media. Tangible, computer-readable media refers to any media that is capable of providing data that causes the computing device 900 (i.e., a machine) to operate in a particular fashion. Various computer-readable media may be utilized to provide instructions to the processing unit 920 for execution. Example tangible, computer-readable media may include, but is not limited to, volatile media, non-volatile media, removable media and non-removable media implemented in any method or technology for storage of information such as computer readable instructions, data structures, program modules or other data. System memory 930, removable storage 940, and non-removable storage 950 are all examples of tangible, computer storage media. Example tangible, computer-readable recording media include, but are not limited to, an integrated circuit (e.g., field-programmable gate array or application-specific IC), a hard disk, an optical disk, a magneto-optical disk, a floppy disk, a magnetic tape, a holographic storage medium, a solid-state device, RAM, ROM, electrically erasable program read-only memory (EEPROM), flash memory or other memory technology, CD-ROM, digital versatile disks (DVD) or other optical storage, magnetic cassettes, magnetic tape, magnetic disk storage or other magnetic storage devices.

It is fundamental to the electrical engineering and software engineering arts that functionality that can be implemented by loading executable software into a computer can be converted to a hardware implementation by well-known design rules. Decisions between implementing a concept in software versus hardware typically hinge on considerations of stability of the design and numbers of units to be produced rather than any issues involved in translating from the software domain to the hardware domain. Generally, a design that is still subject to frequent change may be preferred to be implemented in software, because re-spinning a hardware implementation is more expensive than re-spinning a software design. Generally, a design that is stable that will be produced in large volume may be preferred to be implemented in hardware, for example in an application specific integrated circuit (ASIC), because for large production runs the hardware implementation may be less expensive than the software implementation. Often a design may be developed and tested in a software form and later transformed, by well-known design rules, to an equivalent hardware implementation in an application specific integrated circuit that hardwires the instructions of the software. In the same manner as a machine controlled by a new ASIC is a particular machine or apparatus, likewise a computer that has been programmed and/or loaded with executable instructions may be viewed as a particular machine or apparatus.

In an example implementation, the processing unit 920 may execute program code stored in the system memory 930. For example, the bus may carry data to the system memory 930, from which the processing unit 920 receives and executes instructions. The data received by the system memory 930 may optionally be stored on the removable storage 940 or the non-removable storage 950 before or after execution by the processing unit 920.

It should be understood that the various techniques described herein may be implemented in connection with hardware or software or, where appropriate, with a combination thereof. Thus, the methods and apparatuses of the presently disclosed subject matter, or certain aspects or portions thereof, may take the form of program code (i.e., instructions) embodied in tangible media, such as floppy diskettes, CD-ROMs, hard drives, or any other machine-readable storage medium wherein, when the program code is loaded into and executed by a machine, such as a computing device, the machine becomes an apparatus for practicing the presently disclosed subject matter. In the case of program code execution on programmable computers, the computing device generally includes a processor, a storage medium readable by the processor (including volatile and non-volatile memory and/or storage elements), at least one input device, and at least one output device. One or more programs may implement or utilize the processes described in connection with the presently disclosed subject matter, e.g., through the use of an application programming interface (API), reusable controls, or the like. Such programs may be implemented in a high level procedural or object-oriented programming language to communicate with a computer system. However, the program(s) can be implemented in assembly or machine language, if desired. In any case, the language may be a compiled or interpreted language and it may be combined with hardware implementations.

Implementations of the methods and systems may be described herein with reference to block diagrams and flowchart illustrations of methods, systems, apparatuses and computer program products. It will be understood that each block of the block diagrams and flowchart illustrations, and combinations of blocks in the block diagrams and flowchart illustrations, respectively, can be implemented by computer program instructions. These computer program instructions may be loaded onto a general purpose computer, special purpose computer, or other programmable data processing apparatus to produce a machine, such that the instructions which execute on the computer or other programmable data processing apparatus create a means for implementing the functions specified in the flowchart block or blocks.

These computer program instructions may also be stored in a computer-readable memory that can direct a computer or other programmable data processing apparatus to function in a particular manner, such that the instructions stored in the computer-readable memory produce an article of manufacture including computer-readable instructions for implementing the function specified in the flowchart block or blocks. The computer program instructions may also be loaded onto a computer or other programmable data processing apparatus to cause a series of operational steps to be performed on the computer or other programmable apparatus to produce a computer-implemented process such that the instructions that execute on the computer or other programmable apparatus provide steps for implementing the functions specified in the flowchart block or blocks.

Accordingly, blocks of the block diagrams and flowchart illustrations support combinations of means for performing the specified functions, combinations of steps for performing the specified functions and program instruction means for performing the specified functions. It will also be understood that each block of the block diagrams and flowchart illustrations, and combinations of blocks in the block diagrams and flowchart illustrations, can be implemented by special purpose hardware-based computer systems that perform the specified functions or steps, or combinations of special purpose hardware and computer instructions.

Example

Conventional aspiration systems operate with the vacuum being controlled with a “foot valve” by the operating physician. This is not very precise and is a distraction to the primary job of guiding the catheter. The principle of this system is to automate the process. The reader is directed to the flow chart of FIG. 9 for reference.

The system is controlled by a microprocessor controller (MC). A simple device as compared to a conventional computer and can run “stand alone”. That means all it needs to run is powering it up. The program is written to be failsafe and straightforward. On power up the MC initializes and performs a test of the system and a checksum on the program. Any problem with this stops the process. The system uses a Vacuum Regulator (VR) module. It takes raw unregulated vacuum from a user supplied vacuum pump (VP). The VR can be set to deliver from full to almost zero vacuum buy the MC while the VP is set to maximum vacuum.

Another component of the system is the Flow Sensor (FS). This device measures the amount of blood flow out of the catheter. There are several available technologies for the sensor. The most straight forward and inexpensive is the impeller rotational sensor. It measures the flow by how fast an impeller spins.

An ultrasonic flow sensor works well in this application and can accurately measure the low flow rates that might indicate the possibility of a blockage caused by a blood. A small tube from the catheter is placed in a cavity on the sensor and the velocity of the flow is determined. An electrical pulse train is produced that has a frequency proportional to the flow rate that is read by the MC. The sensor is completely isolated from any liquids and can be used repeatedly, where as the rotational sensor would have to be disposed of after every procedure.

In this example, 100 mL/minute is the upper limit on the flow rate. After power on test is complete, the VR commands full vacuum. The flow can reach 100 m/min quickly, and the MC detects that and quickly commands the VR to reduce vacuum and to control the flow by adjusting the vacuum to a midline flow rate of around 30 m/min. Without the VR, blood flow out of the catheter would be excessive.

The flow rate from 100 m/min to 30 mL/min can be achieved in steps so that the clinician gets enough time to make necessary decisions/actions. Same delay time or stepped approach is taken for the application of full vacuum to the aspiration tubing when the flow rate falls below a lower limit of 10 ml/min (or the tip of the catheter engages a clot, in practice).

If, while the system is regulating to 30 m/min, it drops below 10 m/min, a blockage of the catheter has probably occurred. The system will attempt to “Clear” the blockage, usually caused by encountering a blood clot, by commanding full vacuum power from the VR. As in the beginning, when the flow hits 100 m/min, the MC will command the VR will scale back and regulate to 30 mL/min.

The cycle repeats until the unit is shut off. Before complete shutdown, the MC commands the VR to completely release the vacuum.

The corresponding structures, materials, acts, and equivalents of all means or step plus function elements in the claims below are intended to include any structure, material, or act for performing the function in combination with other claimed elements as specifically claimed. The description of the present invention has been presented for purposes of illustration and description, but is not intended to be exhaustive or limited to the invention in the form disclosed. Many modifications and variations will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the invention. The implementation was chosen and described in order to best explain the principles of the invention and the practical application, and to enable others of ordinary skill in the art to understand the invention for various implementations with various modifications as are suited to the particular use contemplated.

Claims

1. A method of controlling blood loss during thrombus removal, the method comprising:

fluidically connecting a vacuum pump to a vacuum line and fluidically connecting the vacuum line to a receptacle for blood collection;
fluidically connecting the receptacle for blood collection to an aspiration tubing and fluidically connecting the aspiration tubing to an aspiration catheter;
positioning the aspiration catheter within the vascular system of a subject;
activating the vacuum pump;
introducing a vacuum pressure and a flow of air into the vacuum line;
introducing a vacuum pressure within the receptacle;
initiating a flow of blood through the aspiration tubing via the vacuum pressure within the receptacle;
collecting blood within the receptacle;
measuring a flow parameter of the blood within the aspiration tubing using a sensor;
receiving the flow parameter from the sensor at a vacuum controller;
comparing the flow parameter to a target range for the flow parameter;
sending an automatic control signal from the vacuum controller to a regulator based on a comparison of the flow parameter to the target range; and
adjusting the vacuum pressure and flow of air within the vacuum line according to information stored in the automatic control signal, thereby adjusting the vacuum pressure within the receptacle and the flow of blood through the aspiration tubing and the aspiration catheter.

2. The method of claim 1, wherein activating a vacuum pump comprises activating the vacuum pump at full power, and the vacuum controller adjusts the vacuum pressure within the vacuum line while the vacuum pump runs at full power.

3. The method of claim 1, wherein adjusting the vacuum pressure within the vacuum line comprises manipulating a valve that opens the vacuum line to the atmosphere.

4. The method of claim 1, wherein measuring a flow parameter comprises measuring a flow rate.

5. The method of claim 1, further comprising using a plurality of sensors to measure one or more flow parameters of the blood at disparate points along the length of an aspiration lumen extending through the aspiration catheter and the aspiration tubing, and receiving the one or more flow parameters at the vacuum controller.

6. The method of claim 1, further comprising measuring a frequency from the flow parameter at the vacuum controller.

7. The method of claim 1, further comprising detecting air within the aspiration tubing and sending a leak signal to the regulator, the pump, or to the vacuum controller.

8. The method of claim 7, wherein detecting air within the aspiration tubing or sending a leak signal to the regulator or the pump is delayed during a vacuum initialization period.

9. The method of claim 1, further comprising accepting a manual command at a manual input, sending a first manual control signal responsive to the manual command to one or more of the vacuum controller, the regulator, or a receptacle vent, and stopping the vacuum controller from sending automatic control signals to the regulator.

10. The method of claim 9, further comprising forming a second manual control signal at the vacuum controller based on the first manual control signal and sending the second manual control signal to the regulator and/or receptacle vent.

11. The method of claim 9, further comprising receiving the first manual control signal at the regulator and controlling vacuum pressure within the vacuum line based on the manual control signal.

12. The method of claim 9, further comprising receiving the first manual control signal at the receptacle vent and opening or shutting the receptacle vent based on the manual control signal.

13. The method of claim 1, further comprising shifting a switch from a closed configuration to an open configuration, wherein shifting the switch to the open configuration causes a clamp coupled to the aspiration tubing to allow fluid flow through the aspiration tubing, and further comprising receiving a surge protection signal upon shifting of the switch to the open configuration and decreasing the vacuum pressure upon receipt of the surge protection signal.

14. The method of claim 1, further comprising synchronizing the delivery of power between the vacuum pump and the vacuum controller.

15. An aspiration system for controlling blood loss during thrombus removal, the aspiration system comprising:

an aspiration catheter;
an aspiration tubing fluidically coupled to the aspiration catheter;
an aspiration lumen extending through the aspiration catheter and the aspiration tubing;
a sensor configured to measure a blood flow parameter associated with blood within the aspiration lumen;
a receptacle fluidically coupled to the aspiration tubing and configured to collect blood aspirated by the aspiration catheter;
a vacuum line fluidically coupled to the receptacle and configured to transfer a vacuum pressure from a vacuum pump to the receptacle;
a regulator coupled to the vacuum line, the regulator comprising a valve that is configured to open the vacuum line to the atmosphere in order to adjust the vacuum pressure within the vacuum line and within the receptacle; and
a vacuum controller operably coupled to the sensor and the regulator and configured to communicate with the regulator to adjust the vacuum pressure within the vacuum line, the vacuum controller configured to: receive the blood flow parameter from the sensor; compare the blood flow parameter to a target range for the blood flow parameter; and send an automatic control signal to the regulator based on a comparison of the blood flow parameter to the target range;
wherein the automatic control signal causes the regulator to adjust the vacuum pressure within the vacuum line and within the receptacle by manipulating the valve that opens the vacuum line to the atmosphere.

16. The aspiration system of claim 15, wherein the aspiration tubing is fluidically coupled to the receptacle at an intake port, and the vacuum line is fluidically coupled to the receptacle at a vacuum port.

17. The aspiration system of claim 15, wherein the receptacle comprises a receptacle vent in communication with the regulator or the vacuum controller, the receptacle vent configured to open upon receipt of a venting signal from the regulator or vacuum controller.

18. The aspiration system of claim 15, further comprising a plurality of sensors configured to measure one or more parameters associated with blood flow in the aspiration lumen at disparate points along a length of the aspiration lumen and to send measured parameters to the vacuum controller.

19. The aspiration system of claim 15, further comprising an air leak sensor in communication with the vacuum controller or the regulator, the air leak sensor configured to detect air flow through the aspiration tubing and to send a leak signal to the vacuum controller, the regulator, or to a vacuum pump upon detection of air flow through the aspiration tubing.

20. The aspiration system of claim 19, wherein the vacuum controller, the regulator, or the pump are configured to slow or stop a vacuum flow in the vacuum line while the air leak is addressed.

21. The aspiration system of claim 20, wherein the vacuum controller is configured to delay detection of air leaks or to delay controlling the vacuum pressure in response to detection of air leaks during a vacuum initialization period.

22. The aspiration system of claim 15, wherein the vacuum line comprises a disposable portion and a reusable portion, the disposable portion coupled to the reusable portion at a connector.

23. The aspiration system of claim 15, further comprising a power synchronizer configured to detect power changes and cause the system to synchronize a delivery of power between a vacuum pump and the vacuum controller.

24. The aspiration system of claim 15, further comprising a manual input in communication with one or more of the vacuum controller, the regulator, and a receptacle vent, wherein the manual input is configured to accept a manual command and send a manual control signal responsive to the manual command to one or more of the vacuum controller, the regulator, and the receptacle vent.

25. The aspiration system of claim 15, further comprising an indicator in communication with the sensor, the indicator configured to inform a user of a characteristic of the blood flow parameter.

26. The aspiration system of claim 15, wherein the aspiration system further comprises a clamp coupled to the aspiration tubing and a switch operably coupled to the clamp, the switch comprising a closed configuration and an open configuration, wherein the switch in the closed configuration causes the clamp to stop blood flow through the aspiration tubing, and wherein the switch in the open configuration causes the clamp to allow blood flow through the aspiration tubing.

27. The aspiration system of claim 26, wherein the switch is in communication with the vacuum controller and/or the regulator, and shifting the switch to the open configuration sends a surge protection signal to the regulator and/or to the vacuum controller, and wherein upon receipt of the surge protection signal, the regulator and/or the vacuum controller is configured to reduce the vacuum pressure within the vacuum line.

Referenced Cited
U.S. Patent Documents
3693613 September 1972 Kelman
3930505 January 6, 1976 Wallach
4244230 January 13, 1981 Bauer
4332560 June 1, 1982 Rait
4460361 July 17, 1984 Nichols
4654029 March 31, 1987 D'Antonio
4735606 April 5, 1988 Davidson
4935005 June 19, 1990 Haines
5094961 March 10, 1992 DelValle et al.
5195995 March 23, 1993 Walker
5201703 April 13, 1993 Gentelia
5242404 September 7, 1993 Conley et al.
5536242 July 16, 1996 Willard
5606968 March 4, 1997 Mang
5897524 April 27, 1999 Wortrich et al.
5941869 August 24, 1999 Patterson
6013046 January 11, 2000 Maaskamp et al.
6039715 March 21, 2000 Mackool
6055458 April 25, 2000 Cochran et al.
6258053 July 10, 2001 Mackool
6290689 September 18, 2001 Delaney et al.
6319223 November 20, 2001 Wortrich et al.
6514268 February 4, 2003 Finlay et al.
6629646 October 7, 2003 Ivri
6663613 December 16, 2003 Evans et al.
6730063 May 4, 2004 Delaney et al.
6773445 August 10, 2004 Finlay et al.
6790196 September 14, 2004 Kokate et al.
6887220 May 3, 2005 Kataishi et al.
6926208 August 9, 2005 Ivri
6929633 August 16, 2005 Evans et al.
6979293 December 27, 2005 Hansmann et al.
7004931 February 28, 2006 Hogendijk
7108197 September 19, 2006 Ivri
7141045 November 28, 2006 Johansson et al.
7160268 January 9, 2007 Darnell et al.
7244250 July 17, 2007 Miki et al.
7250042 July 31, 2007 Rauker et al.
7276052 October 2, 2007 Kobayashi et al.
7276060 October 2, 2007 Madden
7309334 December 18, 2007 von Hoffmann
7422579 September 9, 2008 Wahr
7491192 February 17, 2009 Di Fiore
7608063 October 27, 2009 Le et al.
7655016 February 2, 2010 Demarais et al.
7666161 February 23, 2010 Nash et al.
7674272 March 9, 2010 Torrance et al.
7713231 May 11, 2010 Wulfman et al.
7713235 May 11, 2010 Torrance et al.
7717934 May 18, 2010 Knsleika
7736355 June 15, 2010 Itou et al.
7762995 July 27, 2010 Eversull et al.
7763010 July 27, 2010 Evans et al.
7780694 August 24, 2010 Palmer et al.
7792647 September 7, 2010 Ding et al.
7842009 November 30, 2010 Torrance et al.
7842010 November 30, 2010 Bonnette et al.
7887510 February 15, 2011 Karpowicz
7918822 April 5, 2011 Kumar et al.
7931659 April 26, 2011 Bose et al.
7935077 May 3, 2011 Thor et al.
7938820 May 10, 2011 Webster et al.
7942852 May 17, 2011 Mas et al.
7947012 May 24, 2011 Spurchise et al.
7959608 June 14, 2011 Nash et al.
7976528 July 12, 2011 Nash et al.
7981128 July 19, 2011 To et al.
7998104 August 16, 2011 Chang
8002728 August 23, 2011 Chang
8007506 August 30, 2011 To et al.
8012117 September 6, 2011 Bonnette et al.
8021351 September 20, 2011 Boldenow et al.
8052640 November 8, 2011 Fiorella et al.
8057439 November 15, 2011 Di Fiore
8066677 November 29, 2011 Lnnn et al.
8066757 November 29, 2011 Ferrera et al.
8070694 December 6, 2011 Galdonik et al.
8070762 December 6, 2011 Escudero et al.
8070791 December 6, 2011 Ferrera et al.
8088103 January 3, 2012 Teeslink et al.
8088140 January 3, 2012 Ferrera et al.
8114106 February 14, 2012 Straub
8137377 March 20, 2012 Palmer et al.
8142442 March 27, 2012 Palmer et al.
8157760 April 17, 2012 Criado et al.
8162878 April 24, 2012 Bonnette et al.
8231600 July 31, 2012 von Hoffmann
8252020 August 28, 2012 Hauser et al.
8262611 September 11, 2012 Teeslink et al.
8298210 October 30, 2012 Provost-Tine et al.
8303538 November 6, 2012 Bonnette et al.
8317748 November 27, 2012 Fiorella et al.
8323240 December 4, 2012 Wulfman et al.
8337516 December 25, 2012 Escudero et al.
8361105 January 29, 2013 Adams et al.
8366663 February 5, 2013 Fiorella et al.
8366735 February 5, 2013 Bose et al.
8388582 March 5, 2013 Enbanks et al.
8388628 March 5, 2013 Eversull et al.
8398589 March 19, 2013 Teeslink et al.
8405568 March 26, 2013 Knudsen et al.
8430837 April 30, 2013 Jenson et al.
8430840 April 30, 2013 Nazarifar et al.
8435228 May 7, 2013 Wulfman et al.
8439878 May 14, 2013 Bonnette et al.
8444661 May 21, 2013 Nair et al.
8460312 June 11, 2013 Bose et al.
8465467 June 18, 2013 Gao
8469970 June 25, 2013 Diamant et al.
8475484 July 2, 2013 Wulfman et al.
8500683 August 6, 2013 Constantz et al.
8529491 September 10, 2013 Beiriger
8535290 September 17, 2013 Evans et al.
8545432 October 1, 2013 Renati et al.
8545514 October 1, 2013 Ferrera
8562555 October 22, 2013 MacMahon et al.
8568432 October 29, 2013 Straub
8574262 November 5, 2013 Ferrera et al.
8585713 November 19, 2013 Ferrera et al.
8591453 November 26, 2013 Stubkjaer et al.
8628549 January 14, 2014 To et al.
8647355 February 11, 2014 Escudero et al.
8652086 February 18, 2014 Gerg et al.
8657785 February 25, 2014 Torrance et al.
8668665 March 11, 2014 Gerg et al.
8679142 March 25, 2014 Slee et al.
8679150 March 25, 2014 Janardhan et al.
8690907 April 8, 2014 Janardhan et al.
8696622 April 15, 2014 Fiorella et al.
8702652 April 22, 2014 Fiorella et al.
8715220 May 6, 2014 Gerg et al.
8715314 May 6, 2014 Janardhan et al.
8715315 May 6, 2014 Janardhan et al.
8715316 May 6, 2014 Janardhan et al.
8715317 May 6, 2014 Janardhan et al.
8721676 May 13, 2014 Janardhan et al.
8721677 May 13, 2014 Janardhan et al.
8728116 May 20, 2014 Janardhan et al.
8728117 May 20, 2014 Janardhan et al.
8733618 May 27, 2014 Janardhan et al.
8735777 May 27, 2014 Janardhan et al.
8747432 June 10, 2014 Janardhan et al.
8753371 June 17, 2014 Janardhan et al.
8758325 June 24, 2014 Webster et al.
8764724 July 1, 2014 Itou et al.
8783151 July 22, 2014 Janardhan et al.
8784355 July 22, 2014 Criado et al.
8784434 July 22, 2014 Rosenbluth et al.
8784446 July 22, 2014 Janardhan et al.
8789452 July 29, 2014 Janardhan et al.
8790365 July 29, 2014 Janardhan et al.
8795330 August 5, 2014 Janardhan et al.
8801749 August 12, 2014 Adams et al.
8803030 August 12, 2014 Janardhan et al.
8813625 August 26, 2014 Janardhan et al.
8814892 August 26, 2014 Galdonik et al.
8816247 August 26, 2014 Janardhan et al.
8828045 September 9, 2014 Janardhan et al.
8845678 September 30, 2014 Janardhan et al.
8845679 September 30, 2014 Janardhan et al.
8852219 October 7, 2014 Wulfman et al.
8852227 October 7, 2014 Janardhan et al.
8859934 October 14, 2014 Janardhan et al.
8863631 October 21, 2014 Janardhan et al.
8866049 October 21, 2014 Janardhan et al.
8869670 October 28, 2014 Janardhan et al.
8870805 October 28, 2014 Chang
8870824 October 28, 2014 Kusakabe
8870901 October 28, 2014 Janardhan et al.
8870910 October 28, 2014 Janardhan et al.
8872068 October 28, 2014 Janardhan et al.
8882797 November 11, 2014 Janardhan et al.
8888801 November 18, 2014 To et al.
8895891 November 25, 2014 Janardhan et al.
8900179 December 2, 2014 Jenson et al.
8900257 December 2, 2014 Straub et al.
8904914 December 9, 2014 Janardhan et al.
8910555 December 16, 2014 Janardhan et al.
8920402 December 30, 2014 Nash et al.
8920448 December 30, 2014 To et al.
8926680 January 6, 2015 Ferrera et al.
8932320 January 13, 2015 Janardhan et al.
8932321 January 13, 2015 Janardhan et al.
8939931 January 27, 2015 von Hoffmann
8940003 January 27, 2015 Slee et al.
8945143 February 3, 2015 Ferrera et al.
8945172 February 3, 2015 Ferrera et al.
8951224 February 10, 2015 Wulfman et al.
8956386 February 17, 2015 Hauser et al.
8970384 March 3, 2015 Yodfat et al.
8986241 March 24, 2015 Evans et al.
8998843 April 7, 2015 Bonnette et al.
9011364 April 21, 2015 Criado et al.
9011467 April 21, 2015 Garrison et al.
9017309 April 28, 2015 Tanikawa et al.
9039715 May 26, 2015 Diamant et al.
9050127 June 9, 2015 Bonnette et al.
9055951 June 16, 2015 Deshpande
9055963 June 16, 2015 Henkes et al.
9072540 July 7, 2015 Jarnagin et al.
9078682 July 14, 2015 Lenker et al.
9095371 August 4, 2015 Escudero et al.
9113936 August 25, 2015 Look et al.
9119656 September 1, 2015 Leynov et al.
9125728 September 8, 2015 Angel et al.
9126018 September 8, 2015 Garrison
9138527 September 22, 2015 Renati et al.
9149568 October 6, 2015 Gerg et al.
9161765 October 20, 2015 Thor et al.
9161766 October 20, 2015 Slee et al.
9179909 November 10, 2015 Garrison et al.
9179931 November 10, 2015 Janardhan et al.
9179995 November 10, 2015 Janardhan et al.
9186487 November 17, 2015 Dubrul et al.
9198679 December 1, 2015 To et al.
9198687 December 1, 2015 Fulkerson et al.
9220522 December 29, 2015 Fulkerson et al.
9238122 January 19, 2016 Malhi et al.
9239049 January 19, 2016 Jarnagin et al.
9241699 January 26, 2016 Kume et al.
9248221 February 2, 2016 Look et al.
9259215 February 16, 2016 Chou et al.
9259237 February 16, 2016 Quick et al.
9265512 February 23, 2016 Garrison et al.
9282989 March 15, 2016 Boukhny et al.
9283040 March 15, 2016 Hendrick
9295373 March 29, 2016 Torrance et al.
9301829 April 5, 2016 Rauker et al.
9308016 April 12, 2016 Escudero et al.
9308315 April 12, 2016 Stubkjaer et al.
9314263 April 19, 2016 Escudero et al.
9314324 April 19, 2016 Janardhan et al.
9320532 April 26, 2016 Ferrera et al.
9332998 May 10, 2016 Ray et al.
9332999 May 10, 2016 Ray et al.
9333007 May 10, 2016 Escudero et al.
9375223 June 28, 2016 Wallace
9387098 July 12, 2016 Ferrera et al.
9399118 July 26, 2016 Kume et al.
9408620 August 9, 2016 Rosenbluth et al.
9408626 August 9, 2016 Tekulve
9408964 August 9, 2016 Breiter et al.
9421080 August 23, 2016 Angel et al.
9427300 August 30, 2016 Angel et al.
9433427 September 6, 2016 Look et al.
9445828 September 20, 2016 Turjman et al.
9445943 September 20, 2016 Wilson et al.
9463035 October 11, 2016 Greenhalgh et al.
9492192 November 15, 2016 To et al.
9492637 November 15, 2016 Garrison et al.
9498604 November 22, 2016 Dubrul et al.
9510854 December 6, 2016 Mallaby
9522258 December 20, 2016 Tekulve
9526504 December 27, 2016 Chang
9526864 December 27, 2016 Quick
9526865 December 27, 2016 Quick
9526874 December 27, 2016 Teeslink et al.
9526922 December 27, 2016 Hossack et al.
9532792 January 3, 2017 Galdonik et al.
9539022 January 10, 2017 Bowman
9549850 January 24, 2017 Sorensen et al.
9554822 January 31, 2017 Consigny
9561345 February 7, 2017 Garrison et al.
9592068 March 14, 2017 Janardhan et al.
9597101 March 21, 2017 Galdonik et al.
9629654 April 25, 2017 Andersen
9649437 May 16, 2017 Eubanks et al.
9655633 May 23, 2017 Leynov et al.
9655755 May 23, 2017 Chou et al.
9656043 May 23, 2017 Bhagchandani et al.
9662118 May 30, 2017 Chang
9662129 May 30, 2017 Galdonik et al.
9662137 May 30, 2017 Jenson et al.
9662480 May 30, 2017 Kume et al.
9668767 June 6, 2017 To et al.
9669191 June 6, 2017 Chou et al.
9675376 June 13, 2017 To et al.
9681882 June 20, 2017 Garrison et al.
9693898 July 4, 2017 Farley et al.
9700332 July 11, 2017 Marchand et al.
9700347 July 11, 2017 Shiber
9707002 July 18, 2017 Henkes et al.
9717519 August 1, 2017 Rosenbluth et al.
9731065 August 15, 2017 Bourne et al.
9737328 August 22, 2017 Bonnette et al.
9750517 September 5, 2017 Agrawal
9750524 September 5, 2017 Janardhan et al.
9775964 October 3, 2017 Eubanks et al.
9789242 October 17, 2017 Criado et al.
9801642 October 31, 2017 Thor et al.
9801643 October 31, 2017 Hansen et al.
9801644 October 31, 2017 Ulm, III
9808266 November 7, 2017 Ray et al.
9808271 November 7, 2017 Ulm, III
9808277 November 7, 2017 Nash et al.
9814478 November 14, 2017 Ulm, III
9820761 November 21, 2017 Garrison et al.
9820764 November 21, 2017 Ulm, III
9826998 November 28, 2017 Ulm, III
9833251 December 5, 2017 Janardhan et al.
9833253 December 5, 2017 Ulm, III
9833257 December 5, 2017 Bonnette et al.
9833555 December 5, 2017 Criado et al.
9839506 December 12, 2017 Ulm, III
9839771 December 12, 2017 Eversull et al.
9844387 December 19, 2017 Marchand et al.
9848881 December 26, 2017 Sutton et al.
9848975 December 26, 2017 Nash et al.
9855375 January 2, 2018 Charron et al.
9861783 January 9, 2018 Garrison et al.
9878076 January 30, 2018 Gulcher et al.
9883877 February 6, 2018 Look et al.
9895158 February 20, 2018 Dixon et al.
9895473 February 20, 2018 Look et al.
9901435 February 27, 2018 Janardhan et al.
9907567 March 6, 2018 Shiber
9913936 March 13, 2018 Look et al.
9925315 March 27, 2018 Eubanks et al.
9931166 April 3, 2018 Sauro et al.
9931447 April 3, 2018 Layser et al.
9943321 April 17, 2018 Nita
9943668 April 17, 2018 Jahrmarkt
9955987 May 1, 2018 Ulm, III
9962177 May 8, 2018 Ulm, III
9962288 May 8, 2018 Yalamanehili
9987028 June 5, 2018 Lowinger et al.
10004531 June 26, 2018 Rosenbluth et al.
10010657 July 3, 2018 Torrance et al.
10016211 July 10, 2018 Ferrera et al.
10016266 July 10, 2018 Hauser
10022139 July 17, 2018 Kobayashi et al.
10039906 August 7, 2018 Kume et al.
10045790 August 14, 2018 Cox et al.
10058339 August 28, 2018 Galdonik et al.
10064643 September 4, 2018 Malhi et al.
10085864 October 2, 2018 Chou et al.
10098651 October 16, 2018 Marchand et al.
10098724 October 16, 2018 Adams et al.
10117669 November 6, 2018 Kobayashi et al.
10117670 November 6, 2018 Kobayashi et al.
10137034 November 27, 2018 Heeren
10143489 December 4, 2018 Kobayashi et al.
10149692 December 11, 2018 Turjman et al.
10149698 December 11, 2018 Wulfman et al.
10154853 December 18, 2018 To et al.
10154854 December 18, 2018 To et al.
10179224 January 15, 2019 Yang et al.
10182940 January 22, 2019 Chandrakant et al.
10183145 January 22, 2019 Yang et al.
10183146 January 22, 2019 Yang et al.
10183147 January 22, 2019 Yang et al.
10188399 January 29, 2019 Chang
10188409 January 29, 2019 Smalling
10192230 January 29, 2019 Look et al.
10201359 February 12, 2019 Fiorella et al.
10213582 February 26, 2019 Garrison et al.
10219814 March 5, 2019 Feltyberger et al.
10226263 March 12, 2019 Look et al.
10226268 March 12, 2019 Ulm, III
10226275 March 12, 2019 Eseudero et al.
10226563 March 12, 2019 Garrison et al.
10226598 March 12, 2019 Chou et al.
10238406 March 26, 2019 Cox et al.
10238853 March 26, 2019 Kume et al.
10251739 April 9, 2019 Janardhan et al.
10258358 April 16, 2019 Ulm, III
10271864 April 30, 2019 Greenhalgh et al.
D847864 May 7, 2019 Janardhan et al.
D847865 May 7, 2019 Janardhan et al.
D847866 May 7, 2019 Janardhan et al.
10278719 May 7, 2019 Ulm, III
10278861 May 7, 2019 Bourne et al.
10285720 May 14, 2019 Gilvarry et al.
10299824 May 28, 2019 Walzman
D850490 June 4, 2019 Janardhan et al.
10307242 June 4, 2019 Walzman
10314608 June 11, 2019 Jenson et al.
10314609 June 11, 2019 Bonnette et al.
10314684 June 11, 2019 Walzman
10314953 June 11, 2019 Ovehinnikov et al.
10321925 June 18, 2019 Ulm, III
10327790 June 25, 2019 Garrison et al.
10335186 July 2, 2019 Rosenbluth et al.
10335260 July 2, 2019 Janardhan et al.
10342571 July 9, 2019 Marchand et al.
10342655 July 9, 2019 Janardhan et al.
10349960 July 16, 2019 Quick
10357242 July 23, 2019 Garrison et al.
10357266 July 23, 2019 Ulm, III
10363054 July 30, 2019 Vale et al.
10369270 August 6, 2019 Stubkjaer et al.
10369346 August 6, 2019 Ryan et al.
10376678 August 13, 2019 Levine
10376685 August 13, 2019 Angel et al.
10383644 August 20, 2019 Molaei et al.
10384034 August 20, 2019 Garrison et al.
10390926 August 27, 2019 Janardhan et al.
10398595 September 3, 2019 Zacharias
10405924 September 10, 2019 Bowe
10413310 September 17, 2019 Ferrera et al.
10420572 September 24, 2019 Ulm, III
10426511 October 1, 2019 Hehrlein
10426885 October 1, 2019 Criado et al.
10441301 October 15, 2019 Vale et al.
10441745 October 15, 2019 Yang et al.
10448969 October 22, 2019 Sutton et al.
10456151 October 29, 2019 Slee et al.
10456555 October 29, 2019 Garrison et al.
10463351 November 5, 2019 Merk et al.
10463386 November 5, 2019 Ogle et al.
10463468 November 5, 2019 Janardhan et al.
10470926 November 12, 2019 Zacharias
10471233 November 12, 2019 Garrison et al.
10485551 November 26, 2019 Turjman et al.
10485564 November 26, 2019 Goyal
10485565 November 26, 2019 Galdonik et al.
10485952 November 26, 2019 Garrison et al.
10492805 December 3, 2019 Culbert et al.
10492809 December 3, 2019 Ulm, III
10499944 December 10, 2019 Mallaby
10517633 December 31, 2019 Nash et al.
10524811 January 7, 2020 Marchand et al.
10531882 January 14, 2020 Anand et al.
10531883 January 14, 2020 DeVille et al.
10537471 January 21, 2020 Look et al.
10561440 February 18, 2020 Look et al.
10569049 February 25, 2020 Garrison et al.
10588655 March 17, 2020 Rosenbluth et al.
10588656 March 17, 2020 Trosper et al.
10595818 March 24, 2020 Levine
10603415 March 31, 2020 Look et al.
10610256 April 7, 2020 Bowman
10617435 April 14, 2020 Vale et al.
10617562 April 14, 2020 Bourne et al.
10624659 April 21, 2020 Gamba et al.
10632245 April 28, 2020 Enbanks et al.
10646239 May 12, 2020 Garrison et al.
10653434 May 19, 2020 Yang et al.
10661053 May 26, 2020 Yang et al.
10682152 June 16, 2020 Vale et al.
10690127 June 23, 2020 Ochoa
10695159 June 30, 2020 Hauser
10702292 July 7, 2020 Look et al.
10702415 July 7, 2020 Charles
10702634 July 7, 2020 Luxon et al.
10709466 July 14, 2020 Bowman et al.
10709832 July 14, 2020 Criado et al.
10716482 July 21, 2020 Anderson et al.
10716583 July 21, 2020 Look et al.
10716880 July 21, 2020 Culbert et al.
10716915 July 21, 2020 Ogle et al.
10722238 July 28, 2020 Sutton et al.
10722239 July 28, 2020 Chang
10722251 July 28, 2020 Garrison et al.
10722253 July 28, 2020 DeVille et al.
10722255 July 28, 2020 Leaker et al.
10729455 August 4, 2020 Goyal et al.
10743893 August 18, 2020 Garrison et al.
10751159 August 25, 2020 Janardhan et al.
10772644 September 15, 2020 Feltyberger et al.
10772649 September 15, 2020 Hansen et al.
10779835 September 22, 2020 Chang
10779855 September 22, 2020 Garrison
10786270 September 29, 2020 Yang et al.
10792056 October 6, 2020 Vale et al.
10799331 October 13, 2020 Hauser
10828061 November 10, 2020 Bonnette et al.
10835257 November 17, 2020 Ferrera et al.
10835271 November 17, 2020 Ma
10835272 November 17, 2020 Yang et al.
10835278 November 17, 2020 Wilke et al.
10835711 November 17, 2020 Yang et al.
10864351 December 15, 2020 Garrison et al.
10864357 December 15, 2020 Kume et al.
10869956 December 22, 2020 Torrance et al.
10874410 December 29, 2020 Scarpine et al.
10874411 December 29, 2020 Ngnyen et al.
10888346 January 12, 2021 Ulm, III
10893881 January 19, 2021 Dixon et al.
10893978 January 19, 2021 Sawicz
10905448 February 2, 2021 Machi
10912577 February 9, 2021 Marchand et al.
10912871 February 9, 2021 Gulcher et al.
10922704 February 16, 2021 Look et al.
10932797 March 2, 2021 Thomas
10932810 March 2, 2021 Malhi et al.
10939931 March 9, 2021 Grandfield et al.
10952757 March 23, 2021 Galdonik et al.
10952882 March 23, 2021 Chou et al.
10959750 March 30, 2021 Wallace
10960178 March 30, 2021 Savastano et al.
10993731 May 4, 2021 Leynov et al.
11013523 May 25, 2021 Arad Hadar
11026709 June 8, 2021 Greenhalgh et al.
11027104 June 8, 2021 Kume et al.
11051832 July 6, 2021 Look et al.
11051978 July 6, 2021 Heeren et al.
11058445 July 13, 2021 Cox et al.
11058451 July 13, 2021 Marchand et al.
11065018 July 20, 2021 Buck et al.
11077288 August 3, 2021 Govari
11083485 August 10, 2021 Kobayashi et al.
11083559 August 10, 2021 Kobayashi et al.
11090070 August 17, 2021 Fiorella et al.
11090071 August 17, 2021 Girdhar et al.
11090466 August 17, 2021 Nicholson
11096703 August 24, 2021 Panian
11096712 August 24, 2021 Teigen et al.
11096715 August 24, 2021 Hatta et al.
11103265 August 31, 2021 Wallace et al.
11116528 September 14, 2021 Wallace
11123090 September 21, 2021 Yang et al.
11129629 September 28, 2021 Welch et al.
11147571 October 19, 2021 Cox et al.
11147949 October 19, 2021 Yang et al.
11160570 November 2, 2021 Skujins et al.
11160571 November 2, 2021 Nguyen et al.
11160572 November 2, 2021 Ulm, III
11185623 November 30, 2021 Ovehinnikov et al.
11185664 November 30, 2021 Garrison et al.
11191558 December 7, 2021 Nguyen et al.
11197683 December 14, 2021 Teigen et al.
11197977 December 14, 2021 Mullins et al.
11207096 December 28, 2021 To et al.
11207456 December 28, 2021 Charron et al.
11224458 January 18, 2022 Savastano et al.
11224721 January 18, 2022 Garrison et al.
11229445 January 25, 2022 Ogle
11229451 January 25, 2022 Guerra et al.
11229770 January 25, 2022 Chou et al.
11234723 February 1, 2022 Ogle
11253277 February 22, 2022 Buck et al.
11259820 March 1, 2022 Walzman
11259821 March 1, 2022 Buck et al.
11266434 March 8, 2022 MeRae et al.
11272945 March 15, 2022 Shrivastava et al.
20030187475 October 2, 2003 Tsugita et al.
20050004594 January 6, 2005 Nool
20050020973 January 27, 2005 MacMahon
20050159716 July 21, 2005 Kobayashi
20050228423 October 13, 2005 Khashayar et al.
20050240146 October 27, 2005 Nash et al.
20070075161 April 5, 2007 Ivri
20070129679 June 7, 2007 Bonnette et al.
20070135779 June 14, 2007 Lalomia et al.
20070239182 October 11, 2007 Glines
20080103433 May 1, 2008 Nazarifar et al.
20080147023 June 19, 2008 Hopkins et al.
20100185150 July 22, 2010 Zacharias
20100191169 July 29, 2010 Chang
20100191170 July 29, 2010 Chang
20100204672 August 12, 2010 Lockhart
20110166496 July 7, 2011 Criado et al.
20120041360 February 16, 2012 Gerg et al.
20120059340 March 8, 2012 Larsson
20130150782 June 13, 2013 Sorensen
20130267919 October 10, 2013 Caso et al.
20140271273 September 18, 2014 Carpenter
20140303658 October 9, 2014 Bonnette et al.
20140323906 October 30, 2014 Peatfield et al.
20150283309 October 8, 2015 Look et al.
20150327875 November 19, 2015 Look et al.
20160089227 March 31, 2016 Loh
20160128869 May 12, 2016 Zacharias
20160296690 October 13, 2016 Kume et al.
20160367272 December 22, 2016 Garrison et al.
20170043066 February 16, 2017 Laub
20170100142 April 13, 2017 Look et al.
20170181760 June 29, 2017 Look
20170239447 August 24, 2017 Yang et al.
20170368309 December 28, 2017 Garrison et al.
20180028359 February 1, 2018 Gordon et al.
20180049920 February 22, 2018 Charles
20180207397 July 26, 2018 Look et al.
20180256177 September 13, 2018 Cooper et al.
20180353194 December 13, 2018 Shaffer et al.
20190108540 April 11, 2019 Look et al.
20190125512 May 2, 2019 Macdonald et al.
20190133616 May 9, 2019 Sachar et al.
20190133617 May 9, 2019 Look et al.
20190142567 May 16, 2019 Janardhan et al.
20190142568 May 16, 2019 Janardhan et al.
20190167287 June 6, 2019 Vale et al.
20190167406 June 6, 2019 Janardhan et al.
20190209745 July 11, 2019 Hanson et al.
20190216476 July 18, 2019 Bose et al.
20190239910 August 8, 2019 Brady et al.
20190262120 August 29, 2019 Walzman
20190274704 September 12, 2019 Jenson et al.
20190307947 October 10, 2019 Stubkjaer
20190328410 October 31, 2019 Look et al.
20190350604 November 21, 2019 Slee et al.
20190351182 November 21, 2019 Chou et al.
20190366042 December 5, 2019 Garrison et al.
20190374128 December 12, 2019 Palushi et al.
20190381223 December 19, 2019 Culbert et al.
20190381303 December 19, 2019 Angel et al.
20190388109 December 26, 2019 Cai
20200015826 January 16, 2020 Chang
20200015840 January 16, 2020 Mallaby
20200016369 January 16, 2020 Garrison et al.
20200022711 January 23, 2020 Look et al.
20200022712 January 23, 2020 Deville et al.
20200023160 January 23, 2020 Chou et al.
20200023164 January 23, 2020 Tran et al.
20200029998 January 30, 2020 Ogle et al.
20200038576 February 6, 2020 Garrison et al.
20200046368 February 13, 2020 Merritt et al.
20200046389 February 13, 2020 Galdonik et al.
20200046939 February 13, 2020 Garrison et al.
20200046940 February 13, 2020 Garrison et al.
20200078029 March 12, 2020 Hansen et al.
20200086083 March 19, 2020 Porter et al.
20200093503 March 26, 2020 Deville et al.
20200121336 April 23, 2020 Tsukamoto et al.
20200121356 April 23, 2020 Look et al.
20200155178 May 21, 2020 Culbert et al.
20200164178 May 28, 2020 Garrison et al.
20200170666 June 4, 2020 Trosper et al.
20200179576 June 11, 2020 Wood
20200179578 June 11, 2020 Look et al.
20200187965 June 18, 2020 Garrison et al.
20200187979 June 18, 2020 Bowman
20200205840 July 2, 2020 Adawi et al.
20200206457 July 2, 2020 Boling
20200206458 July 2, 2020 Mullins et al.
20200214726 July 9, 2020 Anand et al.
20200215306 July 9, 2020 Garrison et al.
20200246014 August 6, 2020 Walzman
20200253624 August 13, 2020 Gamba et al.
20200276411 September 3, 2020 Ogle et al.
20200281610 September 10, 2020 Look et al.
20200281611 September 10, 2020 Kelly et al.
20200289136 September 17, 2020 Chou
20200289722 September 17, 2020 Culbert et al.
20200297362 September 24, 2020 DeVille et al.
20200297363 September 24, 2020 Look et al.
20200297365 September 24, 2020 Bowman et al.
20200297410 September 24, 2020 Nguyen et al.
20200297912 September 24, 2020 Criado et al.
20200315642 October 8, 2020 Greenhalgh et al.
20200316348 October 8, 2020 Ascher et al.
20200324079 October 15, 2020 Jalgaonkar et al.
20200337716 October 29, 2020 Garrison et al.
20200345904 November 5, 2020 Casey et al.
20200345981 November 5, 2020 Garrison et al.
20200352583 November 12, 2020 Goyal et al.
20200367917 November 26, 2020 Teigen et al.
20200375616 December 3, 2020 Fitz et al.
20200376175 December 3, 2020 Hartwell
20200383698 December 10, 2020 Miao et al.
20200397446 December 24, 2020 Chang
20200397451 December 24, 2020 Feltyberger et al.
20200397452 December 24, 2020 Twomey et al.
20200397465 December 24, 2020 Nakano et al.
20200397957 December 24, 2020 Teigen et al.
20210022843 January 28, 2021 Hauser
20210038236 February 11, 2021 Ma
20210038779 February 11, 2021 Lorenzo
20210045758 February 18, 2021 Garrison et al.
20210045760 February 18, 2021 Ulm, III
20210052296 February 25, 2021 Garrison
20210068861 March 11, 2021 Bonnette et al.
20210069467 March 11, 2021 Garrison et al.
20210069468 March 11, 2021 Keating et al.
20210077116 March 18, 2021 Ferrera et al.
20210077134 March 18, 2021 Vale et al.
20210085348 March 25, 2021 Nguyen
20210085931 March 25, 2021 Green et al.
20210093344 April 1, 2021 Janardhan et al.
20210100974 April 8, 2021 Walzman
20210100987 April 8, 2021 Sehultz et al.
20210110419 April 15, 2021 Look et al.
20210113224 April 22, 2021 Dinh
20210121281 April 29, 2021 Walzman
20210128182 May 6, 2021 Teigen et al.
20210128893 May 6, 2021 Twomey et al.
20210138193 May 13, 2021 Garrison et al.
20210138194 May 13, 2021 Garrison et al.
20210153883 May 27, 2021 Casey et al.
20210161544 June 3, 2021 Casey
20210161639 June 3, 2021 Walzman
20210169509 June 10, 2021 Goyal
20210170148 June 10, 2021 Green et al.
20210186534 June 24, 2021 Hunt et al.
20210219998 July 22, 2021 Thomas
20210220109 July 22, 2021 Walzman
20210220528 July 22, 2021 Jalgaonkar et al.
20210228222 July 29, 2021 Porter
20210228844 July 29, 2021 Ogle
20210228847 July 29, 2021 Kume et al.
20210236148 August 5, 2021 Marchand et al.
20210236150 August 5, 2021 Arad Hadar
20210236257 August 5, 2021 Walzman
20210259719 August 26, 2021 Griffin
20210267745 September 2, 2021 Walzman
20210275197 September 9, 2021 Vale et al.
20210298773 September 30, 2021 Echarri et al.
20210298775 September 30, 2021 Nguyen et al.
20210299343 September 30, 2021 Criado et al.
20210322051 October 21, 2021 Hatta et al.
20210322053 October 21, 2021 Kobayashi et al.
20210322738 October 21, 2021 Kume et al.
20210330332 October 28, 2021 Chou et al.
20210338255 November 4, 2021 Alesi et al.
20210346040 November 11, 2021 Panian
20210353314 November 18, 2021 Porter
20210353316 November 18, 2021 Wallace et al.
20210353323 November 18, 2021 Teigen et al.
20210361305 November 25, 2021 Mogi et al.
20210378691 December 9, 2021 Panian
20210378696 December 9, 2021 Yang et al.
20210393280 December 23, 2021 Cortinas Villazon et al.
20220000500 January 6, 2022 Arad Hadar et al.
20220000502 January 6, 2022 Ulm, III et al.
20220000505 January 6, 2022 Hauser
20220000506 January 6, 2022 Hauser
20220000507 January 6, 2022 Hauser
20220008090 January 13, 2022 Look et al.
20220015798 January 20, 2022 Marchand et al.
20220022898 January 27, 2022 Cox et al.
20220022899 January 27, 2022 Girdhar et al.
20220022900 January 27, 2022 Nguyen et al.
20220031931 February 3, 2022 Stout
20220054150 February 24, 2022 Dholakia et al.
20220054151 February 24, 2022 Shiffette
20220054153 February 24, 2022 Albers et al.
20220061870 March 3, 2022 Mintz
20220061871 March 3, 2022 Mintz
20220061872 March 3, 2022 Mintz
20220062588 March 3, 2022 Mintz
20220087696 March 24, 2022 Maini et al.
20220168000 June 2, 2022 Naglreiter et al.
20220338887 October 27, 2022 Nair et al.
Foreign Patent Documents
215386236 January 2022 CN
1996001079 January 1996 WO
2009012473 January 2009 WO
2008157674 December 2009 WO
2010075445 July 2010 WO
2013064852 May 2013 WO
20140151209 September 2014 WO
2017062927 April 2017 WO
2018019829 February 2018 WO
2019213179 November 2019 WO
2020023541 January 2020 WO
20200145928 July 2020 WO
20200167276 August 2020 WO
2021012058 January 2021 WO
2021016213 January 2021 WO
2021073572 April 2021 WO
2021083832 May 2021 WO
2021113962 June 2021 WO
2021113970 June 2021 WO
2021123395 June 2021 WO
2021151969 August 2021 WO
2021178696 September 2021 WO
2021242963 December 2021 WO
20210250133 December 2021 WO
2022020366 January 2022 WO
2022040615 February 2022 WO
2022174175 August 2022 WO
2023092042 May 2023 WO
Other references
  • US 11,191,563 B2, 12/2021, Savastano et al. (withdrawn)
  • International Search Report and Written Opinion issued for Application No. PCT/US2022/025918, dated Jun. 29, 2022.
  • Office Action issued for U.S. Appl. No. 17/726,787, dated Sep. 20, 2022.
  • Office Action issued for U.S. Appl. No. 17/726,787, dated Dec. 1, 2022.
  • Notice of Allowance issued for U.S. Appl. No. 17/726,787, dated Apr. 27, 2023.
  • Office Action issued for U.S. Appl. No. 17/726,788, dated Aug. 9, 2022.
  • Office Action issued for U.S. Appl. No. 17/726,788, dated Dec. 1, 2022.
  • Notice of Allowance issued for U.S. Appl. No. 17/726,788, dated May 5, 2023.
  • Office Action issued for U.S. Appl. No. 17/726,791, dated Jul. 26, 2022.
  • Office Action issued for U.S. Appl. No. 17/726,791, dated Nov. 30, 2022.
  • Notice of Allowance issued for U.S. Appl. No. 17/726,791, dated Apr. 23, 2023.
Patent History
Patent number: 11931502
Type: Grant
Filed: Apr 27, 2023
Date of Patent: Mar 19, 2024
Patent Publication Number: 20230256155
Assignee: Contego Medical, Inc. (Raleigh, NC)
Inventors: Ajit Nair (Pleasanton, CA), Christopher R. Kilgus (Felton, CA), Ravish Sachar (Raleigh, NC)
Primary Examiner: Scott J Medway
Application Number: 18/140,280
Classifications
International Classification: A61M 1/00 (20060101); A61B 17/00 (20060101); A61B 17/22 (20060101); A61B 17/221 (20060101); A61F 2/01 (20060101); A61M 25/00 (20060101);